##fileformat=VCFv4.0
##fileDate=20141105
##source=Atlas-SNP2 v1.4.3 r171
##command="/Atlas-SNP2.rb -i input-0.bam -r ref.0.fa -o output-0 -n 1013_realigned_2.txt.dedup.recaled --Illumina -F"
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=GQ,Number=1,Type=Integer,Description="Genotype Quality">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Read Depth">
##FORMAT=<ID=RR,Number=1,Type=Integer,Description="Reference Read Depth">
##FORMAT=<ID=VR,Number=1,Type=Integer,Description="Major Variant Read Depth">
##FILTER=<ID=low_snpqual,Description="SNP posterior probability lower than 0.95">
##FILTER=<ID=low_VariantReads,Description="Number of variant reads is less than 3">
##FILTER=<ID=low_VariantRatio,Description="Variant read ratio is less than 0.1">
##FILTER=<ID=single_strand,Description="All variant reads are in a single strand direction">
##FILTER=<ID=low_coverage,Description="Total coverage is less than 6">
##FILTER=<ID=high_coverage,Description="Total coverage is more than 1024">
##FILTER=<ID=No_data,Description="No valid reads on this site">
##FILTER=<ID=No_var,Description="No valid variant read on this site">
##META: Cassandra_version=13.10.01
##META: Annovar-refGene(hg19).Version=2013-07-28
##META: Annovar-knownGene(hg19).Version=2013-07-28
##META: Annovar-ensgene(hg19).Version=2013-07-28
##META: Annovar-ensgene(GRCh37_MT).Version=2013-07-28
##META: DbSNP.Description=NCBIs SNP database.Downloaded=2013-09-27. URL = ftp://ftp.ncbi.nih.gov/snp/organisms/human_9606/VCF/00-All.vcf.gz,ftp://ftp.ncbi.nih.gov/snp/organisms/human_9606/VCF/00-All.vcf.gz.tbi
##META: HgmdAll.Database_version=01/12/12.Description=Downloaded from HGMD..Downloaded=Dec 01 2012
##META: ESP5400.Description=The current EVS data release (ESP6500SI-V2) is taken from 6503 samples drawn from multiple ESP cohorts and represents all of the ESP exome variant data..Downloaded=2013-09-27. URL = http://evs.gs.washington.edu/evs_bulk_data/ESP6500SI-V2-SSA137.dbSNP138-rsIDs.snps_indels.vcf.tar.gz
##META: CgMaf.Description=Complete genomics variations from the reference genome identified across 54-genome subset of the 69 CG public genomes..Downloaded=2013-09-27. URL = ftp://ftp2.completegenomics.com/Feb2011_Release/CGA_Tools_Output/Public_Genomes_Unrelated_54-listvariants-Freq.bz2
##META: ESEIndel .Database_version=Proprietary.Description=NA.Downloaded=NA
##META: Mappability.Description=Encode 100bp alignability track.Downloaded=2013-09-27. URL = http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeMapability/wgEncodeCrgMapabilityAlign100mer.bigWig
##META: 1000 Genomes Phase 1.Description=SNPs Indels and SVs friom 1000 Genomes.Downloaded=2013-09-27. URL = ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/phase1/analysis_results/integrated_call_sets/ALL.wgs.integrated_phase1_v3.20101123.snps_indels_sv.sites.vcf.gz,ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/phase1/analysis_results/integrated_call_sets/ALL.wgs.integrated_phase1_v3.20101123.snps_indels_sv.sites.vcf.gz.tbi
##META: Swissprot.Description=Uniprot gene annotation.Downloaded=2013-09-27. URL = ftp://ftp.ebi.ac.uk/pub/databases/uniprot/current_release/knowledgebase/taxonomic_divisions/uniprot_sprot_human.dat.gz
##META: Cosmic.Description=Cosmic annotated coding variants.Downloaded=2013-09-30. URL = ftp://ngs.sanger.ac.uk/production/cosmic/CosmicCodingMuts_v66_20130725.vcf.gz
##META: DbNSFP.Description=The dbNSFP is an integrated database of functional annotations from multiple sources for the comprehensive collection of human non-synonymous SNPs.Downloaded=2013-09-27. URL = http://dbnsfp.houstonbioinformatics.org/dbNSFPzip/dbNSFP2.0b4.zip
##META: Encode.Description=Reglatory features from Encode.Downloaded=2013-09-27. URL = ftp://ftp.ensembl.org/pub/release-73/regulation/homo_sapiens/AnnotatedFeatures.gff.gz
##META: Cosmic.Description=Cosmic annotated non-coding variants.Downloaded=2013-09-30. URL = ftp://ngs.sanger.ac.uk/production/cosmic/CosmicNonCodingVariants_v66_20130725.vcf.gz
##INFO=<ID=AC,Number=.,Type=Integer,Description="Allele count in genotypes">
##INFO=<ID=AF,Number=.,Type=Float,Description="Allele frequency">
##INFO=<ID=ReqIncl,Number=.,Type=String,Description="Site was required to be included in the VCF">
##INFO=<ID=PU,Number=.,Type=String,Description="Pileup data. NB:for compliance with the VCF standard ; has been replaced with : (59-58)">
##INFO=<ID=RFG,Number=.,Type=String,Description="Mutation type (Refseq)">
##INFO=<ID=GI,Number=.,Type=String,Description="Proximal gene information (for noncoding variants)">
##INFO=<ID=UCG,Number=.,Type=String,Description="Mutation type (UCSC)">
##INFO=<ID=ENS,Number=.,Type=String,Description="Mutation type (Ensembl)">
##INFO=<ID=ENSGN,Number=1,Type=String,Description="Ensembl gene name">
##INFO=<ID=MT,Number=.,Type=String,Description="Mitochondrial mutation type (Ensembl)">
##INFO=<ID=MTGN,Number=1,Type=String,Description="Mitochondrial gene name">
##INFO=<ID=GN,Number=.,Type=String,Description="Gene name">
##INFO=<ID=RSID,Number=.,Type=String,Description="DBSNP rsid">
##INFO=<ID=CD,Number=.,Type=String,Description="DBSNP Variant Clinical Significance, 0 - unknown, 1 - untested, 2 - non-pathogenic, 3 - probable-non-pathogenic, 4 - probable-pathogenic, 5 - pathogenic, 6 - drug-response, 7 - histocompatibility, 255 - other">
##INFO=<ID=HT,Number=1,Type=String,Description="HGMD mutation type">
##INFO=<ID=HC,Number=1,Type=String,Description="HGMD variant class">
##INFO=<ID=HD,Number=.,Type=String,Description="HGMD disease">
##INFO=<ID=HP,Number=1,Type=String,Description="HGMD pubmed ID">
##INFO=<ID=AV,Number=1,Type=String,Description="ESP6500 variant count in african americans">
##INFO=<ID=AT,Number=1,Type=String,Description="ESP6500 reference count in african americans">
##INFO=<ID=EV,Number=1,Type=String,Description="ESP6500 variant count in europeans">
##INFO=<ID=ET,Number=1,Type=String,Description="ESP6500 reference count in europeans">
##INFO=<ID=CG,Number=1,Type=String,Description="Complete Genomcs MAF">
##INFO=<ID=IET,Number=1,Type=String,Description="ESE indel-count from TCGA">
##INFO=<ID=IEO,Number=1,Type=String,Description="ESE indel-count from non-TCGA">
##INFO=<ID=IEN,Number=.,Type=String,Description="Near-by indels in ESE">
##INFO=<ID=MS,Number=1,Type=String,Description="100mer mapping score">
##INFO=<ID=TMAF,Number=1,Type=String,Description="Thousand Genomes Allele frequency">
##INFO=<ID=TAMR,Number=1,Type=String,Description="Thousand Genomes AMR AF">
##INFO=<ID=TASN,Number=1,Type=String,Description="Thousand Genomes ASN AF">
##INFO=<ID=TAFR,Number=1,Type=String,Description="Thousand Genomes AFR AF">
##INFO=<ID=TEUR,Number=1,Type=String,Description="Thousand Genomes EUR AF">
##INFO=<ID=SF,Number=.,Type=String,Description="Swiss prot function">
##INFO=<ID=SD,Number=.,Type=String,Description="Swiss prot disease association">
##INFO=<ID=SM,Number=.,Type=String,Description="Swiss prot post translational modifications">
##INFO=<ID=SX,Number=.,Type=String,Description="Swiss prot expression">
##INFO=<ID=CID,Number=1,Type=String,Description="Cosmic ID">
##INFO=<ID=CGENE,Number=1,Type=String,Description="Cosmic gene name">
##INFO=<ID=CSTRAND,Number=1,Type=String,Description="Cosmic gene strand">
##INFO=<ID=CCDS,Number=1,Type=String,Description="Cosmic CDS annotation">
##INFO=<ID=CAA,Number=1,Type=String,Description="Cosmic peptide annotation">
##INFO=<ID=CCNT,Number=1,Type=String,Description="How many Cosmic samples have this mutation">
##INFO=<ID=NA,Number=.,Type=String,Description="nsdb PhyloP score, the larger the score, the more conserved the site.">
##INFO=<ID=NC,Number=.,Type=String,Description="nsdb SIFT score, If a score is smaller than 0.05 the corresponding NS is predicted as 'D(amaging)' otherwise it is predicted as 'T(olerated)'">
##INFO=<ID=NE,Number=.,Type=String,Description="nsdb Polyphen2_HVAR_score: Polyphen2 score based on HumVar, i.e. hvar_prob.The score ranges from 0 to 1, and the corresponding prediction is 'probably damaging' if it is in [0.909,1]; 'possibly damaging' if it is in [0.447,0.908]; 'benign' if it is in [0,0.446]. Score cutoff for binary classification is 0.5, i.e. the prediction is 'neutral' if the score is smaller than 0.5 and 'deleterious' if the score is larger than 0.5. Multiple entries separated by ';'.">
##INFO=<ID=NF,Number=.,Type=String,Description="nsdb Polyphen2_HVAR_pred: Polyphen2 prediction based on HumVar, 'D' ('porobably damaging'),'P' ('possibly damaging') and 'B' ('benign'). Multiple entries separated by ';'.">
##INFO=<ID=NG,Number=.,Type=String,Description="nsdb LRT score">
##INFO=<ID=NH,Number=.,Type=String,Description="nsdb LRT prediction, D(eleterious), N(eutral) or U(nknown)">
##INFO=<ID=NI,Number=.,Type=String,Description="nsdb Mut tatser score">
##INFO=<ID=NJ,Number=.,Type=String,Description="nsdb MutationTaster prediction, 'A' ('disease_causing_automatic'),'D' ('disease_causing'), 'N' ('polymorphism') or 'P' ('polymorphism_automatic')">
##INFO=<ID=NK,Number=.,Type=String,Description="nsdb MutationAssessor functional impact combined score">
##INFO=<ID=NL,Number=.,Type=String,Description="nsdb MutationAssessor 'functional impact of a variant : predicted functional (high, medium), predicted non-functional (low, neutral)' Please refer to Reva et al. Nucl. Acids Res. (2011) 39(17):e118 for details">
##INFO=<ID=NM,Number=.,Type=String,Description="nsdb Interpro_domain: domain or conserved site on which the variant locates. Domain annotations come from Interpro database. The number in the brackets following a specific domain is the count of times Interpro assigns the variant position to that domain, typically coming from different predicting databases. Multiple entries separated by ';'.">
##INFO=<ID=ENN,Number=1,Type=String,Description="Encode Name">
##INFO=<ID=ENC,Number=1,Type=String,Description="Encode class">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	1013_realigned_2.txt.dedup.recaled
1	14610	.	T	C	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=WASH7P,NONE(dist=NONE),NONE(dist=NONE),ENSG00000227232;UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.2;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:3:4:7:.
1	14653	.	C	T	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=WASH7P,NONE(dist=NONE),NONE(dist=NONE),ENSG00000227232;UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=rs375086259;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.25;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:16:15:31:.
1	14677	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=WASH7P,NONE(dist=NONE),NONE(dist=NONE),ENSG00000227232;UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=rs201327123;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.333333;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:24:58:82:.
1	14907	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=WASH7P,NONE(dist=NONE),NONE(dist=NONE),ENSG00000227232;UCG=ncRNA_exonic;ENS=ncRNA_intronic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=rs79585140;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:44:52:96:.
1	14930	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=WASH7P,NONE(dist=NONE),NONE(dist=NONE),ENSG00000227232;UCG=ncRNA_exonic;ENS=ncRNA_intronic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=rs75454623;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:49:58:107:.
1	17365	.	C	G	1	low_snpqual;single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=WASH7P,NONE(dist=NONE),NONE(dist=NONE),ENSG00000227232;UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=rs369606208;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,PolII,H2BK5me1;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:7:22:29:.
1	17375	.	A	G	2	low_snpqual;single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=WASH7P,NONE(dist=NONE),NONE(dist=NONE),ENSG00000227232;UCG=ncRNA_exonic;ENS=ncRNA_intronic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,PolII,H2BK5me1;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:5:20:25:.
1	17538	.	C	A	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=WASH7P,NONE(dist=NONE),NONE(dist=NONE),ENSG00000227232;UCG=ncRNA_exonic;ENS=ncRNA_intronic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=rs200046632;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.125;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,PolII,H2BK5me1;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:5:14:19:.
1	69270	.	A	G	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=OR4F5:NM_001005484:exon1:c.A180G:p.S60S,,NONE(dist=NONE),NONE(dist=NONE),OR4F5:uc001aal.1:exon1:c.A180G:p.S60S,,ENSG00000186092:ENST00000335137:exon1:c.A180G:p.S60S,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000186092;MT=intergenic;MTGN=.;GN=OR4F5;RSID=rs201219564;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.333333;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Odorant_receptor_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H2AZ,H3K36me3,H3K9ac,H3K4me2,DNase1,PolII;ENC=Histone,Open_Chromatin,Polymerase	GT:VR:RR:DP:GQ	1/1:20:0:20:.
1	69511	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=OR4F5:NM_001005484:exon1:c.A421G:p.T141A,,OR4F5:uc001aal.1:exon1:c.A421G:p.T141A,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000186092:ENST00000335137:exon1:c.A421G:p.T141A,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000186092;MT=intergenic;MTGN=.;GN=OR4F5;RSID=rs75062661;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1937;AT=1623;EV=5337;ET=677;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.65;TAMR=0.65;TASN=0.87;TAFR=0.33;TEUR=0.70;SF=Odorant_receptor_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.267000;NC=0.950000;NE=0.0;NF=B;NG=0.000427;NH=N;NI=0.000162;NJ=N;NK=-1.295;NL=neutral;NM=GPCR,_rhodopsin-like_superfamily_(1),;ENN=H3K27me3,H2AZ,H3K36me3,H3K4me2,DNase1,PolII;ENC=Histone,Open_Chromatin,Polymerase	GT:VR:RR:DP:GQ	1/1:259:0:259:.
1	745347	.	T	C	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=LOC100288069(dist=31279),FAM87B(dist=7404),LOC100288069(dist=31279),LINC00115(dist=16239),NONE(dist=NONE),NONE(dist=NONE),ENSG00000237491;UCG=intergenic;ENS=ncRNA_exonic;ENSGN=ENSG00000237491;MT=intergenic;MTGN=.;GN=.;RSID=rs373594198;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.333333;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:10:44:54:.
1	745479	.	T	C	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=LOC100288069(dist=31411),FAM87B(dist=7272),LOC100288069(dist=31411),LINC00115(dist=16107),NONE(dist=NONE),NONE(dist=NONE),ENSG00000230092;UCG=intergenic;ENS=ncRNA_exonic;ENSGN=ENSG00000230092;MT=intergenic;MTGN=.;GN=.;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:4:228:232:.
1	762047	.	T	A	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),ENSG00000225880;UCG=UTR3;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4me2,H3K4ac,H3K27ac,H3K79me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H2BK5ac,H3K36ac,DNase1,E2F6;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/0:3:388:391:.
1	762100	.	T	C	1	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),LINC00115:uc010nxx.2:exon1:c.A472G:p.S158G,,ENSG00000225880;UCG=nonsynonymous_SNV;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4me2,H3K4ac,H3K27ac,H3K79me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H2BK5ac,H3K36ac,DNase1,E2F6,H4K91ac;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/0:7:615:622:.
1	762273	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),LINC00115:uc010nxx.2:exon1:c.C299T:p.P100L,,ENSG00000225880;UCG=nonsynonymous_SNV;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs3115849;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.72;TAMR=0.80;TASN=0.86;TAFR=0.33;TEUR=0.84;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4me2,H3K4ac,H3K27ac,H3K79me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,H4K5ac,Max,CTCF,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:84:2:86:.
1	762330	.	G	T	60	single_strand;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),LINC00115:uc010nxx.2:exon1:c.C242A:p.P81Q,,ENSG00000225880;UCG=nonsynonymous_SNV;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs74045217;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.05;TAMR=0.02;TASN=0.01;TAFR=0.18;TEUR=0.02;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4me2,H3K4ac,H3K27ac,H3K79me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,H4K5ac,Max,CTCF,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/0:11:122:133:.
1	762345	.	A	G	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),LINC00115:uc010nxx.2:exon1:c.T227C:p.L76P,,ENSG00000225880;UCG=nonsynonymous_SNV;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs74045218;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.06;TAMR=0.03;TASN=0.01;TAFR=0.21;TEUR=0.02;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4me2,H3K4ac,H3K27ac,H3K79me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,H4K5ac,Max,CTCF,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:17:127:144:.
1	762589	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),ENSG00000225880;UCG=UTR5;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs71507461;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.73;TAMR=0.78;TASN=0.83;TAFR=0.44;TEUR=0.82;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4ac,H3K27ac,H3K4me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,Max,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp,H4K5ac,Cmyc,ELF1,H2AK9ac,Tr4,Tcf12,TAF1,HEY1,Yy1,Pbx3;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:54:4:58:.
1	762592	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),ENSG00000225880;UCG=UTR5;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs71507462;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.72;TAMR=0.78;TASN=0.83;TAFR=0.43;TEUR=0.81;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4ac,H3K27ac,H3K4me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,Max,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp,H4K5ac,Cmyc,ELF1,H2AK9ac,Tr4,Tcf12,TAF1,HEY1,Yy1,Pbx3;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:56:5:61:.
1	762601	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),ENSG00000225880;UCG=UTR5;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs71507463;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.72;TAMR=0.77;TASN=0.83;TAFR=0.43;TEUR=0.81;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4ac,H3K27ac,H3K4me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,Max,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp,H4K5ac,Cmyc,ELF1,H2AK9ac,Tr4,Tcf12,TAF1,HEY1,Yy1,Pbx3;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:50:6:56:.
1	762632	.	T	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),ENSG00000225880;UCG=UTR5;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs61768173;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.72;TAMR=0.78;TASN=0.82;TAFR=0.44;TEUR=0.81;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4ac,H3K27ac,H3K4me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,Max,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp,H4K5ac,Cmyc,ELF1,H2AK9ac,Tr4,Tcf12,TAF1,HEY1,Yy1,Pbx3;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:76:3:79:.
1	780785	.	T	A	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=LOC643837,NONE(dist=NONE),NONE(dist=NONE),ENSG00000228794;UCG=ncRNA_intronic;ENS=ncRNA_intronic;ENSGN=ENSG00000228794;MT=intergenic;MTGN=.;GN=LOC643837;RSID=rs2977612;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.69;TAMR=0.76;TASN=0.70;TAFR=0.36;TEUR=0.86;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	808631	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=FAM41C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000230368;UCG=ncRNA_intronic;ENS=ncRNA_intronic;ENSGN=ENSG00000230368;MT=intergenic;MTGN=.;GN=FAM41C;RSID=rs11240779;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.50;TAMR=0.68;TASN=0.38;TAFR=0.09;TEUR=0.77;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,CTCF;ENC=Histone,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:22:0:22:.
1	808922	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=FAM41C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000234711;UCG=ncRNA_intronic;ENS=ncRNA_exonic;ENSGN=ENSG00000234711;MT=intergenic;MTGN=.;GN=FAM41C;RSID=rs6594027;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.85;TAMR=0.90;TASN=0.87;TAFR=0.79;TEUR=0.86;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:55:0:55:.
1	808928	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=FAM41C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000234711;UCG=ncRNA_intronic;ENS=ncRNA_exonic;ENSGN=ENSG00000234711;MT=intergenic;MTGN=.;GN=FAM41C;RSID=rs11240780;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.46;TAMR=0.65;TASN=0.37;TAFR=0.09;TEUR=0.69;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:57:0:57:.
1	812267	.	A	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=upstream;GI=FAM41C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000230368;UCG=upstream;ENS=ncRNA_exonic;ENSGN=ENSG00000230368;MT=intergenic;MTGN=.;GN=FAM41C;RSID=rs7541694;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.97;TAMR=0.97;TASN=0.96;TAFR=0.96;TEUR=0.97;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	812284	.	C	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=upstream;GI=FAM41C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000230368;UCG=upstream;ENS=upstream;ENSGN=ENSG00000230368;MT=intergenic;MTGN=.;GN=FAM41C;RSID=rs7545373;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.95;TAMR=0.95;TASN=0.95;TAFR=0.92;TEUR=0.95;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	844324	.	G	A	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=32142),LOC100130417(dist=8629),FAM41C(dist=32142),AK056486(dist=2491),NONE(dist=NONE),NONE(dist=NONE),ENSG00000269308(dist=24341),ENSG00000230699(dist=2491);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs61769714;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.125;TMAF=0.71;TAMR=0.75;TASN=0.59;TAFR=0.66;TEUR=0.80;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,SETDB1;ENC=Histone,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	866319	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634,ENSG00000268179;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs9988021;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.96;TAMR=0.99;TASN=1.00;TAFR=0.83;TEUR=1.00;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:22:0:22:.
1	868891	.	A	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs13303066;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.97;TAMR=0.99;TASN=1.00;TAFR=0.87;TEUR=1.00;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	871334	.	G	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs4072383;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.51;TAMR=0.61;TASN=0.46;TAFR=0.19;TEUR=0.70;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:18:12:30:.
1	874314	.	G	A	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs117605689;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.01;TAMR=0.04;TASN=0.0035;TAFR=.;TEUR=.;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:7:4:11:.
1	876499	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs4372192;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3853;AT=509;EV=8004;ET=532;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.92;TAMR=0.92;TASN=0.92;TAFR=0.86;TEUR=0.95;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,H3K4me3,H3K4me2,H3K9ac,H4K20me1,H3K4me1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:59:1:60:.
1	878314	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=SAMD11:NM_152486:exon11:c.G1440C:p.G480G,,SAMD11:uc001abw.1:exon11:c.G1440C:p.G480G,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634:ENST00000342066:exon11:c.G1440C:p.G480G,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs142558220;CD=.;HT=.;HC=.;HD=.;HP=.;AV=56;AT=4108;EV=550;ET=7674;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.05;TAMR=0.06;TASN=.;TAFR=0.01;TEUR=0.10;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=COSM426784;CGENE=SAMD11;CSTRAND=+;CCDS=c.1440G>C;CAA=p.G480G;CCNT=1;NA=-0.159000;NC=0.340000;NE=.;NF=.;NG=0.000620;NH=D;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,PolII,ZBTB7A,H3K36me3;ENC=Histone,Open_Chromatin,Polymerase,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:23:41:64:.
1	878685	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=SAMD11:NM_152486:exon12:c.C1617G:p.D539E,,SAMD11:uc001abw.1:exon12:c.C1617G:p.D539E,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634:ENST00000342066:exon12:c.C1617G:p.D539E,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.781000;NC=0.070000;NE=0.999,0.999;NF=D,D;NG=0.000000;NH=D;NI=.;NJ=.;NK=1.685;NL=low;NM=Sterile_alpha_motif/pointed_domain_(2),;ENN=H3K27me3,PolII,H3K36me3,DNase1,Max;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:38:27:65:.
1	880238	.	A	G	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs3748592;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.92;TASN=0.92;TAFR=0.90;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,PolII,DNase1;ENC=Histone,Polymerase,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:10:0:10:.
1	881627	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=NOC2L:NM_015658:exon16:c.C1843T:p.L615L,,NOC2L:uc009vjq.3:exon16:c.C1843T:p.L615L,NOC2L:uc001aby.4:exon14:c.C1234T:p.L412L,NOC2L:uc001abz.4:exon16:c.C1843T:p.L615L,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976:ENST00000327044:exon16:c.C1843T:p.L615L,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs2272757;CD=.;HT=.;HC=.;HD=.;HP=.;AV=688;AT=3716;EV=5486;ET=3114;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.47;TAMR=0.46;TASN=0.61;TAFR=0.08;TEUR=0.63;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=COSM1344685;CGENE=NOC2L;CSTRAND=-;CCDS=c.1843C>T;CAA=p.L615L;CCNT=1;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:27:41:68:.
1	882033	.	G	A	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=UTR5;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs2272756;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.15;TAMR=0.23;TASN=0.08;TAFR=0.02;TEUR=0.25;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:5:6:11:.
1	883625	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs4970378;CD=.;HT=.;HC=.;HD=.;HP=.;AV=4374;AT=2;EV=8576;ET=0;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=1.00;TAMR=1.00;TASN=1.00;TAFR=1.00;TEUR=1.00;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:96:0:96:.
1	884091	.	C	G	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs7522415;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	0/1:3:5:8:.
1	884101	.	A	C	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs4970455;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	0/1:4:3:7:.
1	886624	.	G	A	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:3:120:123:.
1	886788	.	G	A	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs10465242;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.72;TAMR=0.74;TASN=0.69;TAFR=0.46;TEUR=0.90;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,CTCF,Rad21,DNase1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	886817	.	C	T	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs10465241;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.72;TAMR=0.74;TASN=0.69;TAFR=0.46;TEUR=0.90;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,CTCF,Rad21,DNase1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	887560	.	A	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs3748595;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3662;AT=744;EV=8021;ET=579;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.84;TAMR=0.86;TASN=0.86;TAFR=0.78;TEUR=0.85;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	1/1:141:0:141:.
1	887801	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=NOC2L:NM_015658:exon10:c.T1182C:p.T394T,,NONE(dist=NONE),NONE(dist=NONE),NOC2L:uc009vjq.3:exon10:c.T1182C:p.T394T,NOC2L:uc001aby.4:exon8:c.T573C:p.T191T,NOC2L:uc001abz.4:exon10:c.T1182C:p.T394T,,ENSG00000188976:ENST00000327044:exon10:c.T1182C:p.T394T,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs3828047;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3992;AT=414;EV=8070;ET=530;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.92;TASN=0.92;TAFR=0.90;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=COSM426785;CGENE=NOC2L;CSTRAND=-;CCDS=c.1182T>C;CAA=p.T394T;CCNT=1;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	1/1:42:0:42:.
1	888639	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=NOC2L:NM_015658:exon9:c.A918G:p.E306E,,NONE(dist=NONE),NONE(dist=NONE),NOC2L:uc009vjq.3:exon9:c.A918G:p.E306E,NOC2L:uc001aby.4:exon7:c.A309G:p.E103E,NOC2L:uc001abz.4:exon9:c.A918G:p.E306E,,ENSG00000188976:ENST00000327044:exon9:c.A918G:p.E306E,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs3748596;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3991;AT=415;EV=8069;ET=531;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.92;TASN=0.92;TAFR=0.90;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:262:2:264:.
1	888659	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=NOC2L:NM_015658:exon9:c.A898G:p.I300V,,NONE(dist=NONE),NONE(dist=NONE),NOC2L:uc009vjq.3:exon9:c.A898G:p.I300V,NOC2L:uc001aby.4:exon7:c.A289G:p.I97V,NOC2L:uc001abz.4:exon9:c.A898G:p.I300V,,ENSG00000188976:ENST00000327044:exon9:c.A898G:p.I300V,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs3748597;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3989;AT=415;EV=8070;ET=530;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.92;TASN=0.92;TAFR=0.90;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.578000;NC=1.000000;NE=0.0;NF=B;NG=0.069598;NH=N;NI=0.000000;NJ=P;NK=-2.24;NL=neutral;NM=Armadillo-type_fold_(1),;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:228:0:228:.
1	889158	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=splicing;GI=NOC2L(NM_015658:exon9:c.888+4C>G),NONE(dist=NONE),NONE(dist=NONE),NOC2L(uc001aby.4:exon7:c.279+4C>G,uc001abz.4:exon9:c.888+4C>G,uc009vjq.3:exon9:c.888+4C>G),ENSG00000188976(ENST00000327044:exon9:c.888+4C>G);UCG=splicing;ENS=splicing;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13303056;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3628;AT=776;EV=8023;ET=573;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.85;TAMR=0.87;TASN=0.88;TAFR=0.79;TEUR=0.85;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:37:0:37:.
1	889159	.	A	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=splicing;GI=NOC2L(NM_015658:exon9:c.888+3T>G),NOC2L(uc001aby.4:exon7:c.279+3T>G,uc001abz.4:exon9:c.888+3T>G,uc009vjq.3:exon9:c.888+3T>G),NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976(ENST00000327044:exon9:c.888+3T>G);UCG=splicing;ENS=splicing;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13302945;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3626;AT=778;EV=8014;ET=582;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.85;TAMR=0.87;TASN=0.88;TAFR=0.79;TEUR=0.85;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:37:0:37:.
1	889638	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=UTR5;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13303206;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.90;TASN=0.92;TAFR=0.83;TEUR=0.94;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:8:0:8:.
1	889713	.	C	A	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=UTR5;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13303051;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.90;TAMR=0.90;TASN=0.92;TAFR=0.83;TEUR=0.94;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	892745	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=UTR5;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13303227;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.92;TASN=0.92;TAFR=0.90;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:8:0:8:.
1	894573	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13303010;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1243;AT=3125;EV=7685;ET=883;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.65;TAMR=0.71;TASN=0.69;TAFR=0.18;TEUR=0.90;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K4me3,H3K4me2,H3K9ac,H3K79me2,H3K27ac,DNase1,H4K91ac,Yy1,Gabp,PolII,Cmyc,Sin3Ak20,ELF1,E2F6,TAF1,HEY1,Max,E2F4;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	1/1:74:1:75:.
1	897325	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=KLHL17:NM_198317:exon4:c.G609C:p.A203A,,KLHL17:uc001aca.2:exon4:c.G609C:p.A203A,KLHL17:uc001acb.1:exon2:c.G237C:p.A79A,KLHL17:uc010nya.1:exon2:c.G237C:p.A79A,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961:ENST00000338591:exon4:c.G609C:p.A203A,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs4970441;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3204;AT=1200;EV=7965;ET=635;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.87;TAMR=0.88;TASN=0.92;TAFR=0.71;TEUR=0.94;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:136:0:136:.
1	897564	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),KLHL17:uc001acb.1:exon2:c.T476C:p.F159S,KLHL17:uc010nya.1:exon2:c.T476C:p.F159S,,ENSG00000187961;UCG=nonsynonymous_SNV;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs13303229;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.91;TASN=0.92;TAFR=0.83;TEUR=0.94;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:13:0:13:.
1	898323	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs6605071;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3992;AT=318;EV=8018;ET=504;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.91;TASN=0.92;TAFR=0.92;TEUR=0.95;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:9:0:9:.
1	899928	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs6677386;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2615;AT=849;EV=6481;ET=467;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.83;TAMR=0.86;TASN=0.92;TAFR=0.56;TEUR=0.92;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:59:0:59:.
1	899937	.	G	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs143296006;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2305;AT=815;EV=5805;ET=435;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.76;TAMR=0.82;TASN=0.87;TAFR=0.49;TEUR=0.83;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:36:1:37:.
1	899938	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs147467971;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.77;TAMR=0.82;TASN=0.88;TAFR=0.51;TEUR=0.83;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:33:0:33:.
1	899942	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs71509448;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2296;AT=784;EV=5857;ET=393;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.78;TAMR=0.83;TASN=0.91;TAFR=0.49;TEUR=0.86;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:29:1:30:.
1	899989	.	A	C	2	low_snpqual;low_coverage;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs6669071;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.25;TMAF=0.84;TAMR=0.87;TASN=0.91;TAFR=0.64;TEUR=0.91;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=COSN394513;CGENE=KLHL17;CSTRAND=+;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:2:0:2:.
1	900285	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs4970435;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.81;TAMR=0.85;TASN=0.92;TAFR=0.45;TEUR=0.94;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:9:0:9:.
1	900286	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs4970434;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.91;TASN=0.92;TAFR=0.93;TEUR=0.95;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:9:0:9:.
1	906448	.	T	C	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=PLEKHN1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187583;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/0:3:81:84:.
1	909238	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=PLEKHN1:NM_001160184:exon13:c.G1355C:p.R452P,PLEKHN1:NM_032129:exon14:c.G1460C:p.R487P,,PLEKHN1:uc001acf.3:exon13:c.G1355C:p.R452P,PLEKHN1:uc001acd.3:exon14:c.G1460C:p.R487P,PLEKHN1:uc001ace.3:exon13:c.G1616C:p.R539P,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187583:ENST00000379409:exon13:c.G1616C:p.R539P,ENSG00000187583:ENST00000491024:exon2:c.G155C:p.R52P,ENSG00000187583:ENST00000379407:exon13:c.G1355C:p.R452P,ENSG00000187583:ENST00000379410:exon14:c.G1460C:p.R487P,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs3829740;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3431;AT=963;EV=5009;ET=3579;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.74;TAMR=0.67;TASN=0.89;TAFR=0.81;TEUR=0.61;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.456000;NC=0.280000;NE=0.0,0.0,0.0;NF=B,B,B;NG=0.413783;NH=N;NI=0.000026;NJ=N;NK=-0.55;NL=neutral;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:32:44:76:.
1	909555	.	A	G	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=PLEKHN1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187583;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs2340594;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.94;TASN=0.97;TAFR=0.72;TEUR=0.98;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:11:0:11:.
1	909768	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=PLEKHN1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187583;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs2340593;CD=.;HT=.;HC=.;HD=.;HP=.;AV=4404;AT=2;EV=8600;ET=0;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=1.00;TAMR=1.00;TASN=1.00;TAFR=1.00;TEUR=1.00;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:58:0:58:.
1	911595	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,C1orf170:uc001ach.2:exon5:c.T1988C:p.V663A,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642:ENST00000341290:exon5:c.T1988C:p.V663A,ENSG00000187642:ENST00000433179:exon5:c.T2048C:p.V683A,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs7417106;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.74;TAMR=0.77;TASN=0.93;TAFR=0.41;TEUR=0.78;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.265000;NC=0.000000;NE=0.103;NF=B;NG=0.174340;NH=N;NI=0.027941;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,H3K4me2,CTCF,Gabp,Rad21,H4K20me1,H3K4me3;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:144:3:147:.
1	912049	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs9803103;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.54;TAMR=0.58;TASN=0.71;TAFR=0.22;TEUR=0.59;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,H4K20me1,H3K4me3,H3K4me2;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:66:0:66:.
1	912103	.	G	A	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs9803017;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.2;TMAF=0.48;TAMR=0.53;TASN=0.55;TAFR=0.32;TEUR=0.49;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:17:0:17:.
1	912127	.	C	A	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	914192	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs2340595;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.92;TAMR=0.93;TASN=1.00;TAFR=0.77;TEUR=0.96;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:34:1:35:.
1	914333	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,C1orf170:uc001ach.2:exon3:c.G1735C:p.E579Q,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642:ENST00000341290:exon3:c.G1735C:p.E579Q,ENSG00000187642:ENST00000433179:exon3:c.G1795C:p.E599Q,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs13302979;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.57;TAMR=0.61;TASN=0.79;TAFR=0.23;TEUR=0.61;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.888000;NC=0.460000;NE=0.0;NF=B;NG=0.001941;NH=N;NI=0.000018;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:19:1:20:.
1	914526	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.G1542A:p.S514S,,ENSG00000187642:ENST00000341290:exon3:c.G1542A:p.S514S,ENSG00000187642:ENST00000433179:exon3:c.G1602A:p.S534S,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:26:32:58:.
1	914852	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.C1216G:p.Q406E,,ENSG00000187642:ENST00000341290:exon3:c.C1216G:p.Q406E,ENSG00000187642:ENST00000433179:exon3:c.C1276G:p.Q426E,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs13303368;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.53;TAMR=0.59;TASN=0.71;TAFR=0.19;TEUR=0.60;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.049000;NC=1.000000;NE=0.0;NF=B;NG=0.000001;NH=N;NI=0.000015;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:58:0:58:.
1	914876	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.A1192G:p.S398G,,ENSG00000187642:ENST00000341290:exon3:c.A1192G:p.S398G,ENSG00000187642:ENST00000433179:exon3:c.A1252G:p.S418G,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs13302983;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.96;TAMR=0.94;TASN=0.99;TAFR=0.92;TEUR=0.96;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.248000;NC=0.430000;NE=0.004;NF=B;NG=0.211142;NH=N;NI=0.000786;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:87:0:87:.
1	914940	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.A1128G:p.A376A,,ENSG00000187642:ENST00000341290:exon3:c.A1128G:p.A376A,ENSG00000187642:ENST00000433179:exon3:c.A1188G:p.A396A,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs13303033;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.52;TAMR=0.57;TASN=0.71;TAFR=0.18;TEUR=0.59;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:102:2:104:.
1	915227	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.T841C:p.L281L,,ENSG00000187642:ENST00000341290:exon3:c.T841C:p.L281L,ENSG00000187642:ENST00000433179:exon3:c.T901C:p.L301L,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs13303355;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.93;TASN=1.00;TAFR=0.72;TEUR=0.96;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:42:0:42:.
1	916549	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642:ENST00000433179:exon2:c.T58C:p.W20R,;UCG=UTR5;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs6660139;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.74;TAMR=0.74;TASN=0.87;TAFR=0.57;TEUR=0.76;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.945000;NC=0.370000;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:97:0:97:.
1	935222	.	C	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=HES4:NM_001142467:exon1:c.G132T:p.R44S,,NONE(dist=NONE),NONE(dist=NONE),HES4:uc010nyc.1:exon1:c.G132T:p.R44S,,ENSG00000188290:ENST00000428771:exon1:c.G132T:p.R44S,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000188290;MT=intergenic;MTGN=.;GN=HES4;RSID=rs2298214;CD=.;HT=.;HC=.;HD=.;HP=.;AV=455;AT=2827;EV=4195;ET=3171;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.51;TAMR=0.59;TASN=0.76;TAFR=0.05;TEUR=0.59;SF=Transcriptional_repressor._Binds_DNA_on_N-box_motifs:_5'-CACNAG-3'_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-1.612000;NC=1.000000;NE=0.001;NF=B;NG=.;NH=.;NI=.;NJ=.;NK=0;NL=neutral;NM=.;ENN=H3K27me3,DNase1,E2F6,H3K4me3,H3K9ac,PolII,H3K4me2,E2F1,TAF1,Ap2alpha;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	1/1:12:0:12:.
1	936111	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=upstream;GI=HES4,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188290;UCG=upstream;ENS=upstream;ENSGN=ENSG00000188290;MT=intergenic;MTGN=.;GN=HES4;RSID=rs1936360;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.54;TAMR=0.60;TASN=0.75;TAFR=0.20;TEUR=0.58;SF=Transcriptional_repressor._Binds_DNA_on_N-box_motifs:_5'-CACNAG-3'_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,E2F6,H3K4me3,H3K9ac,PolII,TAF1,Ap2gamma,Max,E2F4,ZBTB7A,Cmyc,H3K4me2,H3K27ac,HEY1,H4K91ac,H2AZ,H3K18ac,SETDB1,H4K20me1,Sin3Ak20,Srf,Gabp,Jund,Cjun,USF1,Junb;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	1/1:19:0:19:.
1	943468	.	T	C	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=HES4(dist=7916),ISG15(dist=5379),NONE(dist=NONE),NONE(dist=NONE),ENSG00000231702;UCG=intergenic;ENS=ncRNA_exonic;ENSGN=ENSG00000231702;MT=intergenic;MTGN=.;GN=.;RSID=rs3121567;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.62;TEUR=0.96;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	948870	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR5;GI=ISG15,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187608;UCG=UTR5;ENS=UTR5;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs4615788;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1016;AT=358;EV=3015;ET=141;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.90;TAMR=0.93;TASN=1.00;TAFR=0.67;TEUR=0.96;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K27ac,H3K9ac,H3K4me3,H3K4me2,DNase1,Max,Cmyc,PolII,H2BK5ac,TAF1,ELF1,HEY1,Ap2gamma,Sin3Ak20,MEF2A,Ap2alpha,Srf,Tcf12,FAIRE,H3K36me3,POU2F2,H3K79me2,H2AZ;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	1/1:57:0:57:.
1	948921	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR5;GI=ISG15,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187608;UCG=UTR5;ENS=UTR5;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs15842;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3294;AT=1110;EV=8223;ET=375;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.90;TAMR=0.93;TASN=1.00;TAFR=0.67;TEUR=0.96;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K27ac,H3K9ac,H3K4me3,H3K4me2,DNase1,Max,Cmyc,PolII,H2BK5ac,TAF1,ELF1,HEY1,Ap2gamma,Sin3Ak20,MEF2A,Ap2alpha,Srf,Tcf12,FAIRE,H3K36me3,POU2F2,H3K79me2,H2AZ,H3K18ac,Znf263,H3K9me1;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	1/1:99:1:100:.
1	949235	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ISG15,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187608;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs2465124;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.92;TASN=1.00;TAFR=0.65;TEUR=0.96;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K27ac,H3K9ac,H3K4me3,H3K4me2,DNase1,H2BK5ac,PolII,H3K36me3,H3K79me2,H2AZ,H3K18ac,Znf263,H3K9me1,H4K91ac,H3K4me1,H2BK5me1,H2BK20ac,H4K20me1;ENC=Histone,Open_Chromatin,Polymerase,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:9:0:9:.
1	949654	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=ISG15:NM_005101:exon2:c.A294G:p.V98V,,ISG15:uc001acj.4:exon2:c.A294G:p.V98V,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187608:ENST00000379389:exon2:c.A294G:p.V98V,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs8997;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2526;AT=1880;EV=8142;ET=456;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.82;TAMR=0.90;TASN=0.92;TAFR=0.45;TEUR=0.94;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27ac,H3K9ac,H3K4me2,H3K4me3,H3K27me3,PolII,H3K36me3,H3K79me2,H4K91ac,DNase1;ENC=Histone,Polymerase,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:67:0:67:.
1	949925	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=downstream;GI=ISG15,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187608;UCG=downstream;ENS=downstream;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs2799070;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.87;TAMR=0.92;TASN=0.97;TAFR=0.58;TEUR=0.95;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27ac,H3K9ac,H3K4me3,H3K27me3,PolII,H3K36me3,H3K79me2,H3K4me2,H4K91ac,DNase1,Yy1;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:9:0:9:.
1	974199	.	C	T	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2465131;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.69;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,PU1,SP1,DNase1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	977203	.	G	C	59	low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3121552;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.69;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	977330	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2799066;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3167;AT=1235;EV=7915;ET=681;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.67;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:52:0:52:.
1	977570	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2710876;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2083;AT=2203;EV=7804;ET=682;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.81;TAMR=0.91;TASN=0.97;TAFR=0.37;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:22:0:22:.
1	980460	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128097;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.94;TASN=1.00;TAFR=0.76;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:89:3:92:.
1	981087	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128098;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2850;AT=1556;EV=7972;ET=628;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.87;TAMR=0.92;TASN=1.00;TAFR=0.60;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:52:0:52:.
1	981931	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=AGRN:NM_198576:exon18:c.A3066G:p.S1022S,,NONE(dist=NONE),NONE(dist=NONE),AGRN:uc001ack.2:exon18:c.A3066G:p.S1022S,,ENSG00000188157:ENST00000379370:exon18:c.A3066G:p.S1022S,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2465128;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2316;AT=2080;EV=7819;ET=775;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.82;TAMR=0.90;TASN=0.96;TAFR=0.45;TEUR=0.91;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=COSM1126908;CGENE=AGRN;CSTRAND=+;CCDS=c.3066A>G;CAA=p.S1022S;CCNT=1;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:50:0:50:.
1	982444	.	A	G	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128099;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.84;TAMR=0.92;TASN=0.97;TAFR=0.49;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	982462	.	T	C	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128100;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.98;TAMR=0.98;TASN=1.00;TAFR=0.92;TEUR=1.00;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	982513	.	T	C	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128101;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.92;TAMR=0.94;TASN=1.00;TAFR=0.80;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	982941	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128102;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2098;AT=2308;EV=7869;ET=727;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.82;TAMR=0.91;TASN=0.97;TAFR=0.41;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:97:0:97:.
1	982994	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=AGRN:NM_198576:exon21:c.T3558C:p.F1186F,,NONE(dist=NONE),NONE(dist=NONE),AGRN:uc001ack.2:exon21:c.T3558C:p.F1186F,,ENSG00000188157:ENST00000379370:exon21:c.T3558C:p.F1186F,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs10267;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2389;AT=2017;EV=7901;ET=699;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.84;TAMR=0.91;TASN=0.99;TAFR=0.49;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:190:0:190:.
1	984302	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=AGRN:NM_198576:exon24:c.T4161C:p.T1387T,,NONE(dist=NONE),NONE(dist=NONE),AGRN:uc001ack.2:exon24:c.T4161C:p.T1387T,,ENSG00000188157:ENST00000379370:exon24:c.T4161C:p.T1387T,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs9442391;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1203;AT=3103;EV=4672;ET=3832;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.57;TAMR=0.62;TASN=0.81;TAFR=0.24;TEUR=0.57;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:98:1:99:.
1	985266	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2275813;CD=.;HT=.;HC=.;HD=.;HP=.;AV=693;AT=3681;EV=4482;ET=4010;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.53;TAMR=0.61;TASN=0.80;TAFR=0.10;TEUR=0.55;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:54:0:54:.
1	985446	.	G	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2275812;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.31;TAMR=0.43;TASN=0.25;TAFR=0.06;TEUR=0.45;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:15:1:16:.
1	985449	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2799067;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.47;TAMR=0.52;TASN=0.51;TAFR=0.26;TEUR=0.56;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:9:4:13:.
1	986443	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2710887;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.81;TAMR=0.88;TASN=1.00;TAFR=0.36;TEUR=0.91;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:75:0:75:.
1	987200	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=splicing;GI=AGRN(NM_198576:exon33:c.5651+5C>T),AGRN(uc001ack.2:exon33:c.5651+5C>T),NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157(ENST00000379370:exon33:c.5651+5C>T,ENST00000419249:exon6:c.558+5C>T);UCG=splicing;ENS=splicing;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs9803031;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2016;AT=2386;EV=7824;ET=774;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.81;TAMR=0.89;TASN=1.00;TAFR=0.37;TEUR=0.91;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:147:0:147:.
1	987670	.	T	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs13303287;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.94;TASN=1.00;TAFR=0.82;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	988932	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2710871;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.78;TAMR=0.88;TASN=1.00;TAFR=0.35;TEUR=0.86;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:32:0:32:.
1	990280	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=AGRN:NM_198576:exon36:c.C6057T:p.D2019D,,NONE(dist=NONE),NONE(dist=NONE),AGRN:uc001ack.2:exon36:c.C6057T:p.D2019D,,ENSG00000188157:ENST00000379370:exon36:c.C6057T:p.D2019D,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs4275402;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1425;AT=2865;EV=5921;ET=2473;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.62;TAMR=0.69;TASN=0.80;TAFR=0.26;TEUR=0.69;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:120:1:121:.
1	990517	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000242590;UCG=UTR3;ENS=ncRNA_exonic;ENSGN=ENSG00000242590;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2710872;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.92;TASN=1.00;TAFR=0.83;TEUR=0.88;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:13:0:13:.
1	998582	.	G	C	59	low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=AGRN(dist=7083),RNF223(dist=8544),BC033949(uc001acl.1:exon3:c.347+1G>C),NONE(dist=NONE),NONE(dist=NONE),ENSG00000217801;UCG=ncRNA_splicing;ENS=ncRNA_exonic;ENSGN=ENSG00000217801;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3813194;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.52;TAMR=0.62;TASN=0.77;TAFR=0.08;TEUR=0.56;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H4K20me1,H3K4me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	1002932	.	C	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=AGRN(dist=11433),RNF223(dist=4194),NONE(dist=NONE),NONE(dist=NONE),BC033949(dist=1099),RNF223(dist=4194),ENSG00000217801;UCG=intergenic;ENS=ncRNA_intronic;ENSGN=ENSG00000217801;MT=intergenic;MTGN=.;GN=.;RSID=rs4246502;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.81;TAMR=0.81;TASN=0.92;TAFR=0.78;TEUR=0.74;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H4K20me1,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	1003053	.	C	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=AGRN(dist=11554),RNF223(dist=4073),NONE(dist=NONE),NONE(dist=NONE),BC033949(dist=1220),RNF223(dist=4073),ENSG00000217801;UCG=intergenic;ENS=ncRNA_intronic;ENSGN=ENSG00000217801;MT=intergenic;MTGN=.;GN=.;RSID=rs4074992;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.49;TAMR=0.59;TASN=0.77;TAFR=0.08;TEUR=0.50;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H4K20me1,DNase1,ZEB1;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	1009478	.	G	C	2	low_snpqual;low_coverage;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR5;GI=RNF223,NONE(dist=NONE),NONE(dist=NONE),ENSG00000237330;UCG=UTR5;ENS=UTR5;ENSGN=ENSG00000237330;MT=intergenic;MTGN=.;GN=RNF223;RSID=rs9442367;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.80;TAMR=0.78;TASN=0.92;TAFR=0.80;TEUR=0.72;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K4me3,PolII,DNase1,H3K36me3;ENC=Histone,Polymerase,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:2:0:2:.
1	1011637	.	A	T	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=RNF223(dist=1950),C1orf159(dist=5561),NONE(dist=NONE),NONE(dist=NONE),ENSG00000237330(dist=1950),ENSG00000131591(dist=5561);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs374272466;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.0384615;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	1018144	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=C1orf159,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131591;UCG=UTR3;ENS=UTR3;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs9442395;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.56;TAMR=0.63;TASN=0.77;TAFR=0.26;TEUR=0.56;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:14:0:14:.
1	1019175	.	C	G	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131591;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs2298215;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.71;TAMR=0.75;TASN=0.90;TAFR=0.46;TEUR=0.72;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:7:0:7:.
1	1019180	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131591;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs9442396;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.61;TAMR=0.65;TASN=0.77;TAFR=0.46;TEUR=0.57;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:8:0:8:.
1	1021415	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131591;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs3737728;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3413;AT=987;EV=6204;ET=2392;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.80;TAMR=0.78;TASN=0.91;TAFR=0.79;TEUR=0.72;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:31:0:31:.
1	1026707	.	C	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131591:ENST00000477196:exon4:c.G120T:p.G40G,ENSG00000131591:ENST00000427787:exon4:c.G120T:p.G40G,ENSG00000131591:ENST00000467751:exon4:c.G120T:p.G40G,;UCG=intronic;ENS=synonymous_SNV;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs4074137;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.65;TAMR=0.65;TASN=0.94;TAFR=0.38;TEUR=0.60;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1,H4K20me1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:58:0:58:.
1	1026801	.	T	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131591;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs4562563;CD=.;HT=.;HC=.;HD=.;HP=.;AV=577;AT=803;EV=1955;ET=1223;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.65;TAMR=0.72;TASN=0.87;TAFR=0.39;TEUR=0.61;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1,H4K20me1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:60:0:60:.
1	1115994	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=TTLL10,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162571;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162571;MT=intergenic;MTGN=.;GN=TTLL10;RSID=rs13376597;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1623;AT=2569;EV=1144;ET=7132;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.23;TAMR=0.20;TASN=0.19;TAFR=0.42;TEUR=0.14;SF=Inactive_polyglycylase.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1,ELF1;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:36:43:79:.
1	1116231	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=TTLL10:NM_153254:exon4:c.T527C:p.V176A,TTLL10:NM_001130045:exon8:c.T746C:p.V249A,,TTLL10:uc001acy.2:exon8:c.T746C:p.V249A,TTLL10:uc010nyg.1:exon8:c.T746C:p.V249A,TTLL10:uc001acz.2:exon4:c.T527C:p.V176A,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162571:ENST00000379289:exon8:c.T746C:p.V249A,ENSG00000162571:ENST00000379288:exon4:c.T527C:p.V176A,ENSG00000162571:ENST00000379290:exon8:c.T746C:p.V249A,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000162571;MT=intergenic;MTGN=.;GN=TTLL10;RSID=rs13374146;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1603;AT=2737;EV=586;ET=7928;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.15;TAMR=0.15;TASN=0.05;TAFR=0.38;TEUR=0.08;SF=Inactive_polyglycylase.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.055000;NC=0.920000;NE=0.0,0.0;NF=B,B;NG=0.034773;NH=N;NI=0.000047;NJ=N;NK=-0.975;NL=neutral;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:32:32:64:.
1	1118212	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=TTLL10,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162571;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162571;MT=intergenic;MTGN=.;GN=TTLL10;RSID=rs10907171;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3210;AT=1078;EV=2148;ET=6210;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.56;TAMR=0.51;TASN=0.76;TAFR=0.81;TEUR=0.26;SF=Inactive_polyglycylase.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:32:57:89:.
1	1118275	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=TTLL10:NM_153254:exon7:c.C717T:p.C239C,TTLL10:NM_001130045:exon11:c.C936T:p.C312C,,NONE(dist=NONE),NONE(dist=NONE),TTLL10:uc001acy.2:exon11:c.C936T:p.C312C,TTLL10:uc010nyg.1:exon11:c.C936T:p.C312C,TTLL10:uc001acz.2:exon7:c.C717T:p.C239C,,ENSG00000162571:ENST00000379289:exon11:c.C936T:p.C312C,ENSG00000162571:ENST00000379288:exon7:c.C717T:p.C239C,ENSG00000162571:ENST00000379290:exon11:c.C936T:p.C312C,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000162571;MT=intergenic;MTGN=.;GN=TTLL10;RSID=rs61733845;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1688;AT=2698;EV=418;ET=8166;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.14;TAMR=0.14;TASN=0.05;TAFR=0.38;TEUR=0.04;SF=Inactive_polyglycylase.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:67:113:180:.
1	1147243	.	A	C	2	low_snpqual;low_coverage;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=TNFRSF4,NONE(dist=NONE),NONE(dist=NONE),ENSG00000186827;UCG=intronic;ENS=intronic;ENSGN=ENSG00000186827;MT=intergenic;MTGN=.;GN=TNFRSF4;RSID=rs2298211;CD=.;HT=.;HC=.;HD=.;HP=.;AV=142;AT=3180;EV=432;ET=6784;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.09;TAMR=0.05;TASN=0.15;TAFR=0.05;TEUR=0.09;SF=Receptor_for_TNFSF4/OX40L/GP34.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:2:1:3:.
1	1147422	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=TNFRSF4:NM_003327:exon5:c.G534A:p.E178E,,TNFRSF4:uc001adf.3:exon4:c.G546A:p.E182E,TNFRSF4:uc001ade.3:exon5:c.G534A:p.E178E,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000186827:ENST00000379236:exon5:c.G534A:p.E178E,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000186827;MT=intergenic;MTGN=.;GN=TNFRSF4;RSID=rs17568;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1662;AT=2718;EV=1756;ET=6800;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.45;TAMR=0.48;TASN=0.76;TAFR=0.47;TEUR=0.21;SF=Receptor_for_TNFSF4/OX40L/GP34.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.250000;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,H4K91ac;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:38:35:73:.
1	1153113	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=SDF4:NM_016547:exon7:c.C984T:p.L328L,,NONE(dist=NONE),NONE(dist=NONE),SDF4:uc001adi.4:exon7:c.C984T:p.L328L,,ENSG00000078808:ENST00000263741:exon7:c.C984T:p.L328L,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000078808;MT=intergenic;MTGN=.;GN=SDF4;RSID=rs12036216;CD=.;HT=.;HC=.;HD=.;HP=.;AV=455;AT=3949;EV=920;ET=7680;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.14;TAMR=0.06;TASN=0.27;TAFR=0.09;TEUR=0.11;SF=Isoform_5_may_be_involved_in_the_exocytosis_of_zymogens_by_pancreatic_acini.;SD=.;SM=.;SX=Ubiquitous._Isoform_5_is_expressed_in_pancreas.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:14:4:18:.
1	1158631	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=SDF4:NM_016176:exon4:c.T570C:p.D190D,SDF4:NM_016547:exon4:c.T570C:p.D190D,,SDF4:uc001adj.1:exon2:c.T204C:p.D68D,SDF4:uc001adh.4:exon4:c.T570C:p.D190D,SDF4:uc001adi.4:exon4:c.T570C:p.D190D,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000078808:ENST00000545427:exon4:c.T570C:p.D190D,ENSG00000078808:ENST00000263741:exon4:c.T570C:p.D190D,ENSG00000078808:ENST00000465727:exon4:c.T570C:p.D190D,ENSG00000078808:ENST00000360001:exon4:c.T570C:p.D190D,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000078808;MT=intergenic;MTGN=.;GN=SDF4;RSID=rs6603781;CD=.;HT=.;HC=.;HD=.;HP=.;AV=4313;AT=93;EV=7652;ET=948;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.94;TAMR=0.93;TASN=1.00;TAFR=1.00;TEUR=0.87;SF=Isoform_5_may_be_involved_in_the_exocytosis_of_zymogens_by_pancreatic_acini.;SD=.;SM=.;SX=Ubiquitous._Isoform_5_is_expressed_in_pancreas.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-2.462000;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1,PolII,Pbx3,BCL3;ENC=Histone,Polymerase,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:129:1:130:.
1	1159485	.	C	T	2	low_snpqual;low_coverage;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SDF4,NONE(dist=NONE),NONE(dist=NONE),ENSG00000078808;UCG=intronic;ENS=intronic;ENSGN=ENSG00000078808;MT=intergenic;MTGN=.;GN=SDF4;RSID=rs75700266;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.12;TAMR=0.07;TASN=0.19;TAFR=0.13;TEUR=0.10;SF=Isoform_5_may_be_involved_in_the_exocytosis_of_zymogens_by_pancreatic_acini.;SD=.;SM=.;SX=Ubiquitous._Isoform_5_is_expressed_in_pancreas.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:2:2:4:.
1	1163804	.	C	T	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SDF4,NONE(dist=NONE),NONE(dist=NONE),ENSG00000078808;UCG=intronic;ENS=intronic;ENSGN=ENSG00000078808;MT=intergenic;MTGN=.;GN=SDF4;RSID=rs7515488;CD=.;HT=.;HC=.;HD=.;HP=.;AV=911;AT=3477;EV=1234;ET=7342;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.19;TAMR=0.14;TASN=0.21;TAFR=0.25;TEUR=0.16;SF=Isoform_5_may_be_involved_in_the_exocytosis_of_zymogens_by_pancreatic_acini.;SD=.;SM=.;SX=Ubiquitous._Isoform_5_is_expressed_in_pancreas.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1;ENC=Histone	GT:VR:RR:DP:GQ	0/1:7:10:17:.
1	1177893	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=FAM132A,NONE(dist=NONE),NONE(dist=NONE),ENSG00000184163;UCG=UTR3;ENS=UTR3;ENSGN=ENSG00000184163;MT=intergenic;MTGN=.;GN=FAM132A;RSID=rs12410680;CD=.;HT=.;HC=.;HD=.;HP=.;AV=5;AT=4117;EV=8;ET=7992;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.02;TAMR=0.08;TASN=0.02;TAFR=0.0020;TEUR=0.0040;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:15:7:22:.
1	1178245	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=FAM132A:NM_001014980:exon7:c.G780A:p.T260T,,FAM132A:uc001adl.2:exon7:c.G780A:p.T260T,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000184163:ENST00000330388:exon7:c.G780A:p.T260T,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000184163;MT=intergenic;MTGN=.;GN=FAM132A;RSID=rs11260566;CD=.;HT=.;HC=.;HD=.;HP=.;AV=991;AT=3365;EV=786;ET=7782;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.17;TAMR=0.08;TASN=0.20;TAFR=0.33;TEUR=0.10;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:30:28:58:.
1	1178482	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=FAM132A:NM_001014980:exon6:c.T691C:p.C231R,,FAM132A:uc001adl.2:exon6:c.T691C:p.C231R,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000184163:ENST00000330388:exon6:c.T691C:p.C231R,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000184163;MT=intergenic;MTGN=.;GN=FAM132A;RSID=rs78555129;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1222;AT=3080;EV=743;ET=7787;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.18;TAMR=0.08;TASN=0.20;TAFR=0.34;TEUR=0.10;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.815000;NC=1.000000;NE=0.0;NF=B;NG=0.000000;NH=N;NI=0.000160;NJ=N;NK=-1.94;NL=neutral;NM=Tumour_necrosis_factor-like_(2),;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:34:41:75:.
1	1178925	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=FAM132A:NM_001014980:exon5:c.C539T:p.A180V,,FAM132A:uc001adl.2:exon5:c.C539T:p.A180V,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000184163:ENST00000330388:exon5:c.C539T:p.A180V,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000184163;MT=intergenic;MTGN=.;GN=FAM132A;RSID=rs12093154;CD=.;HT=.;HC=.;HD=.;HP=.;AV=525;AT=3639;EV=674;ET=7594;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.14;TAMR=0.05;TASN=0.20;TAFR=0.19;TEUR=0.10;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=2.252000;NC=0.160000;NE=0.359;NF=B;NG=0.000190;NH=D;NI=0.729052;NJ=P;NK=2.155;NL=medium;NM=Tumour_necrosis_factor-like_(1),;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:43:41:84:.
1	1179030	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=FAM132A,NONE(dist=NONE),NONE(dist=NONE),ENSG00000184163;UCG=intronic;ENS=intronic;ENSGN=ENSG00000184163;MT=intergenic;MTGN=.;GN=FAM132A;RSID=rs111673713;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.15;TAMR=0.06;TASN=0.20;TAFR=0.23;TEUR=0.10;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:11:5:16:.
1	1179309	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=FAM132A,NONE(dist=NONE),NONE(dist=NONE),ENSG00000184163;UCG=intronic;ENS=intronic;ENSGN=ENSG00000184163;MT=intergenic;MTGN=.;GN=FAM132A;RSID=rs113164957;CD=.;HT=.;HC=.;HD=.;HP=.;AV=474;AT=3660;EV=699;ET=7667;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.14;TAMR=0.06;TASN=0.20;TAFR=0.19;TEUR=0.10;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:59:55:114:.
1	1179983	.	G	A	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=FAM132A,NONE(dist=NONE),NONE(dist=NONE),ENSG00000184163;UCG=intronic;ENS=intronic;ENSGN=ENSG00000184163;MT=intergenic;MTGN=.;GN=FAM132A;RSID=rs76342560;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.17;TAMR=0.07;TASN=0.20;TAFR=0.31;TEUR=0.10;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,Znf263,DNase1,H4K20me1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:6:7:13:.
1	1198618	.	T	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=UBE2J2,NONE(dist=NONE),NONE(dist=NONE),ENSG00000160087;UCG=intronic;ENS=intronic;ENSGN=ENSG00000160087;MT=intergenic;MTGN=.;GN=UBE2J2;RSID=rs12563338;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.30;TAMR=0.31;TASN=0.66;TAFR=0.29;TEUR=0.04;SF=Catalyzes_the_covalent_attachment_of_ubiquitin_to_other_proteins._Seems_to_function_in_the_selective_degradation_of_misfolded_membrane_proteins_from_the_endoplasmic_reticulum_(ERAD)_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:8:6:14:.
1	1225553	.	C	T	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SCNN1D,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162572;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162572;MT=intergenic;MTGN=.;GN=SCNN1D;RSID=rs5026410;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Sodium_permeable_non-voltage-sensitive_ion_channel_inhibited_by_the_diuretic_amiloride._Mediates_the_electrodiffusion_of_the_luminal_sodium_(and_water,_which_follows_osmotically)_through_the_apical_membrane_of_epithelial_cells._Controls_the_reabsorption_of_sodium_in_kidney,_colon,_lung_and_sweat_glands._Also_plays_a_role_in_taste_perception.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1,H4K20me1,Cmyc,H3K9me3,CTCF,Rad21;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:11:9:20:.
1	1225612	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SCNN1D,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162572;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162572;MT=intergenic;MTGN=.;GN=SCNN1D;RSID=rs1570866;CD=.;HT=.;HC=.;HD=.;HP=.;AV=965;AT=3391;EV=1073;ET=7503;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.18;TAMR=0.25;TASN=0.17;TAFR=0.24;TEUR=0.11;SF=Sodium_permeable_non-voltage-sensitive_ion_channel_inhibited_by_the_diuretic_amiloride._Mediates_the_electrodiffusion_of_the_luminal_sodium_(and_water,_which_follows_osmotically)_through_the_apical_membrane_of_epithelial_cells._Controls_the_reabsorption_of_sodium_in_kidney,_colon,_lung_and_sweat_glands._Also_plays_a_role_in_taste_perception.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1,H4K20me1,Cmyc,CTCF,Rad21;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:41:45:86:.
1	1225641	.	C	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SCNN1D,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162572;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162572;MT=intergenic;MTGN=.;GN=SCNN1D;RSID=rs2748384;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2841;AT=1525;EV=950;ET=7626;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.48;TAMR=0.29;TASN=0.82;TAFR=0.77;TEUR=0.11;SF=Sodium_permeable_non-voltage-sensitive_ion_channel_inhibited_by_the_diuretic_amiloride._Mediates_the_electrodiffusion_of_the_luminal_sodium_(and_water,_which_follows_osmotically)_through_the_apical_membrane_of_epithelial_cells._Controls_the_reabsorption_of_sodium_in_kidney,_colon,_lung_and_sweat_glands._Also_plays_a_role_in_taste_perception.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1,H4K20me1,CTCF,Rad21;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:58:69:127:.
1	1225959	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SCNN1D,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162572;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162572;MT=intergenic;MTGN=.;GN=SCNN1D;RSID=rs1570867;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2754;AT=1620;EV=1125;ET=7463;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.52;TAMR=0.45;TASN=0.89;TAFR=0.73;TEUR=0.13;SF=Sodium_permeable_non-voltage-sensitive_ion_channel_inhibited_by_the_diuretic_amiloride._Mediates_the_electrodiffusion_of_the_luminal_sodium_(and_water,_which_follows_osmotically)_through_the_apical_membrane_of_epithelial_cells._Controls_the_reabsorption_of_sodium_in_kidney,_colon,_lung_and_sweat_glands._Also_plays_a_role_in_taste_perception.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3,H4K20me1,DNase1,CTCF;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:36:33:69:.
1	1226102	.	G	A	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SCNN1D,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162572;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162572;MT=intergenic;MTGN=.;GN=SCNN1D;RSID=rs2273274;CD=.;HT=.;HC=.;HD=.;HP=.;AV=989;AT=3367;EV=130;ET=8438;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.27;TAMR=0.23;TASN=0.57;TAFR=0.33;TEUR=0.02;SF=Sodium_permeable_non-voltage-sensitive_ion_channel_inhibited_by_the_diuretic_amiloride._Mediates_the_electrodiffusion_of_the_luminal_sodium_(and_water,_which_follows_osmotically)_through_the_apical_membrane_of_epithelial_cells._Controls_the_reabsorption_of_sodium_in_kidney,_colon,_lung_and_sweat_glands._Also_plays_a_role_in_taste_perception.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3,H4K20me1,CTCF;ENC=Histone,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:10:8:18:.
1	1226221	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SCNN1D,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162572;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162572;MT=intergenic;MTGN=.;GN=SCNN1D;RSID=rs2273275;CD=.;HT=.;HC=.;HD=.;HP=.;AV=790;AT=588;EV=408;ET=2754;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.47;TAMR=0.43;TASN=0.84;TAFR=0.58;TEUR=0.12;SF=Sodium_permeable_non-voltage-sensitive_ion_channel_inhibited_by_the_diuretic_amiloride._Mediates_the_electrodiffusion_of_the_luminal_sodium_(and_water,_which_follows_osmotically)_through_the_apical_membrane_of_epithelial_cells._Controls_the_reabsorption_of_sodium_in_kidney,_colon,_lung_and_sweat_glands._Also_plays_a_role_in_taste_perception.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H4K20me1,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:19:20:39:.
1	1226231	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SCNN1D,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162572;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162572;MT=intergenic;MTGN=.;GN=SCNN1D;RSID=rs13306638;CD=.;HT=.;HC=.;HD=.;HP=.;AV=468;AT=3862;EV=73;ET=8483;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.07;TAMR=0.09;TASN=0.06;TAFR=0.17;TEUR=0.01;SF=Sodium_permeable_non-voltage-sensitive_ion_channel_inhibited_by_the_diuretic_amiloride._Mediates_the_electrodiffusion_of_the_luminal_sodium_(and_water,_which_follows_osmotically)_through_the_apical_membrane_of_epithelial_cells._Controls_the_reabsorption_of_sodium_in_kidney,_colon,_lung_and_sweat_glands._Also_plays_a_role_in_taste_perception.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H4K20me1,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:21:23:44:.
1	1226348	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SCNN1D,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162572;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162572;MT=intergenic;MTGN=.;GN=SCNN1D;RSID=rs586965;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2846;AT=1502;EV=1055;ET=7497;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.46;TAMR=0.35;TASN=0.74;TAFR=0.74;TEUR=0.12;SF=Sodium_permeable_non-voltage-sensitive_ion_channel_inhibited_by_the_diuretic_amiloride._Mediates_the_electrodiffusion_of_the_luminal_sodium_(and_water,_which_follows_osmotically)_through_the_apical_membrane_of_epithelial_cells._Controls_the_reabsorption_of_sodium_in_kidney,_colon,_lung_and_sweat_glands._Also_plays_a_role_in_taste_perception.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H4K20me1,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:60:64:124:.
1	1226757	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=SCNN1D:NM_001130413:exon18:c.G2176A:p.G726S,,SCNN1D:uc001adx.2:exon14:c.G1051A:p.G351S,SCNN1D:uc001adt.1:exon18:c.G2176A:p.G726S,SCNN1D:uc001adv.2:exon14:c.G1684A:p.G562S,SCNN1D:uc001adw.2:exon15:c.G1882A:p.G628S,SCNN1D:uc001adu.1:exon17:c.G1684A:p.G562S,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162572:ENST00000338555:exon15:c.G1684A:p.G562S,ENSG00000162572:ENST00000379116:exon18:c.G2176A:p.G726S,ENSG00000162572:ENST00000400928:exon14:c.G1684A:p.G562S,ENSG00000162572:ENST00000325425:exon15:c.G1882A:p.G628S,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000162572;MT=intergenic;MTGN=.;GN=SCNN1D;RSID=rs6690013;CD=.;HT=.;HC=.;HD=.;HP=.;AV=402;AT=3900;EV=324;ET=8136;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.11;TAMR=0.11;TASN=0.13;TAFR=0.16;TEUR=0.05;SF=Sodium_permeable_non-voltage-sensitive_ion_channel_inhibited_by_the_diuretic_amiloride._Mediates_the_electrodiffusion_of_the_luminal_sodium_(and_water,_which_follows_osmotically)_through_the_apical_membrane_of_epithelial_cells._Controls_the_reabsorption_of_sodium_in_kidney,_colon,_lung_and_sweat_glands._Also_plays_a_role_in_taste_perception.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.219000;NC=0.400000;NE=0.052,0.088,0.088;NF=B,B,B;NG=.;NH=.;NI=0.006241;NJ=N;NK=0.55;NL=neutral;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:80:77:157:.
1	1226889	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=SCNN1D:NM_001130413:exon18:c.G2308A:p.G770R,,NONE(dist=NONE),NONE(dist=NONE),SCNN1D:uc001adx.2:exon14:c.G1183A:p.G395R,SCNN1D:uc001adt.1:exon18:c.G2308A:p.G770R,SCNN1D:uc001adv.2:exon14:c.G1816A:p.G606R,SCNN1D:uc001adw.2:exon15:c.G2014A:p.G672R,SCNN1D:uc001adu.1:exon17:c.G1816A:p.G606R,,ENSG00000162572:ENST00000338555:exon15:c.G1816A:p.G606R,ENSG00000162572:ENST00000379116:exon18:c.G2308A:p.G770R,ENSG00000162572:ENST00000400928:exon14:c.G1816A:p.G606R,ENSG00000162572:ENST00000325425:exon15:c.G2014A:p.G672R,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000162572;MT=intergenic;MTGN=.;GN=SCNN1D;RSID=rs609805;CD=.;HT=.;HC=.;HD=.;HP=.;AV=443;AT=3895;EV=239;ET=8279;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.10;TAMR=0.11;TASN=0.13;TAFR=0.17;TEUR=0.04;SF=Sodium_permeable_non-voltage-sensitive_ion_channel_inhibited_by_the_diuretic_amiloride._Mediates_the_electrodiffusion_of_the_luminal_sodium_(and_water,_which_follows_osmotically)_through_the_apical_membrane_of_epithelial_cells._Controls_the_reabsorption_of_sodium_in_kidney,_colon,_lung_and_sweat_glands._Also_plays_a_role_in_taste_perception.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-1.836000;NC=0.490000;NE=0.001,0.001,0.003;NF=B,B,B;NG=0.042969;NH=N;NI=0.007589;NJ=N;NK=0.695;NL=neutral;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:26:37:63:.
1	1229680	.	G	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ACAP3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131584;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131584;MT=intergenic;MTGN=.;GN=ACAP3;RSID=rs2477781;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.98;TAMR=0.99;TASN=1.00;TAFR=0.99;TEUR=0.96;SF=GTPase-activating_protein_for_the_ADP_ribosylation_factor_family_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1,H4K20me1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:8:0:8:.
1	1231507	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ACAP3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131584;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131584;MT=intergenic;MTGN=.;GN=ACAP3;RSID=rs619608;CD=.;HT=.;HC=.;HD=.;HP=.;AV=519;AT=3869;EV=430;ET=8158;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.12;TAMR=0.12;TASN=0.16;TAFR=0.17;TEUR=0.05;SF=GTPase-activating_protein_for_the_ADP_ribosylation_factor_family_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:47:62:109:.
1	1232907	.	G	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ACAP3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131584;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131584;MT=intergenic;MTGN=.;GN=ACAP3;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=GTPase-activating_protein_for_the_ADP_ribosylation_factor_family_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	1232908	.	C	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ACAP3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131584;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131584;MT=intergenic;MTGN=.;GN=ACAP3;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=GTPase-activating_protein_for_the_ADP_ribosylation_factor_family_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:4:1:5:.
1	1232999	.	A	T	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ACAP3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131584;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131584;MT=intergenic;MTGN=.;GN=ACAP3;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=GTPase-activating_protein_for_the_ADP_ribosylation_factor_family_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	1/1:8:0:8:.
1	1233131	.	G	T	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ACAP3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131584;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131584;MT=intergenic;MTGN=.;GN=ACAP3;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=GTPase-activating_protein_for_the_ADP_ribosylation_factor_family_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:9:23:32:.
1	1233132	.	C	T	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ACAP3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131584;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131584;MT=intergenic;MTGN=.;GN=ACAP3;RSID=rs188547671;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.11;TAMR=0.09;TASN=0.15;TAFR=0.17;TEUR=0.05;SF=GTPase-activating_protein_for_the_ADP_ribosylation_factor_family_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:9:25:34:.
1	1233941	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ACAP3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131584;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131584;MT=intergenic;MTGN=.;GN=ACAP3;RSID=rs1739855;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3133;AT=1265;EV=636;ET=7954;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.46;TAMR=0.27;TASN=0.73;TAFR=0.84;TEUR=0.09;SF=GTPase-activating_protein_for_the_ADP_ribosylation_factor_family_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:29:33:62:.
1	1235710	.	T	A	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ACAP3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131584;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131584;MT=intergenic;MTGN=.;GN=ACAP3;RSID=rs640712;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.46;TAMR=0.27;TASN=0.73;TAFR=0.84;TEUR=0.09;SF=GTPase-activating_protein_for_the_ADP_ribosylation_factor_family_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,Nrsf,H2BK5me1,CTCF,H4K20me1,DNase1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:3:5:8:.
1	1237036	.	T	C	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ACAP3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131584;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131584;MT=intergenic;MTGN=.;GN=ACAP3;RSID=rs2477782;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.46;TAMR=0.27;TASN=0.73;TAFR=0.84;TEUR=0.09;SF=GTPase-activating_protein_for_the_ADP_ribosylation_factor_family_(Potential).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:4:2:6:.
1	1245368	.	G	A	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=PUSL1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000169972;UCG=intronic;ENS=intronic;ENSGN=ENSG00000169972;MT=intergenic;MTGN=.;GN=PUSL1;RSID=rs11590283;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.38;TAMR=0.50;TASN=0.02;TAFR=0.08;TEUR=0.80;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=PolII,H3K4me3,H3K36me3,H3K4me2,H4K20me1,DNase1,USF1;ENC=Polymerase,Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:5:2:7:.
1	1246004	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=PUSL1,NONE(dist=NONE),NONE(dist=NONE),PUSL1:uc009vjx.3:exon3:c.A38G:p.Y13C,,ENSG00000169972;UCG=nonsynonymous_SNV;ENS=intronic;ENSGN=ENSG00000169972;MT=intergenic;MTGN=.;GN=PUSL1;RSID=rs2296474;CD=.;HT=.;HC=.;HD=.;HP=.;AV=4362;AT=44;EV=8343;ET=257;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.96;TAMR=0.99;TASN=0.91;TAFR=0.99;TEUR=0.97;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,PolII,DNase1;ENC=Histone,Polymerase,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:58:0:58:.
1	1247494	.	T	C	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=CPSF3L:NM_001256460:exon17:c.A1554G:p.P518P,CPSF3L:NM_001256463:exon14:c.A1338G:p.P446P,CPSF3L:NM_017871:exon16:c.A1641G:p.P547P,CPSF3L:NM_001256456:exon18:c.A1659G:p.P553P,CPSF3L:NM_001256462:exon14:c.A1347G:p.P449P,,NONE(dist=NONE),NONE(dist=NONE),UNKNOWN,ENSG00000127054:ENST00000540437:exon18:c.A1659G:p.P553P,ENSG00000127054:ENST00000421495:exon13:c.A867G:p.P289P,ENSG00000127054:ENST00000545578:exon17:c.A1554G:p.P518P,ENSG00000127054:ENST00000450926:exon16:c.A1575G:p.P525P,ENSG00000127054:ENST00000419704:exon14:c.A1338G:p.P446P,ENSG00000127054:ENST00000411962:exon14:c.A1347G:p.P449P,ENSG00000127054:ENST00000435064:exon16:c.A1641G:p.P547P,;UCG=unknown;ENS=synonymous_SNV;ENSGN=ENSG00000127054;MT=intergenic;MTGN=.;GN=CPSF3L;RSID=rs12103;CD=.;HT=.;HC=.;HD=.;HP=.;AV=874;AT=3504;EV=6892;ET=1654;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.39;TAMR=0.51;TASN=0.02;TAFR=0.11;TEUR=0.81;SF=Catalytic_component_of_the_Integrator_complex,_a_complex_involved_in_the_small_nuclear_RNAs_(snRNA)_U1_and_U2_transcription_and_in_their_3'-box-dependent_processing._The_Integrator_complex_is_associated_with_the_C-terminal_domain_(CTD)_of_RNA_polymerase_II_largest_subunit_(POLR2A)_and_is_recruited_to_the_U1_and_U2_snRNAs_genes._Mediates_the_snRNAs_3'_cleavage.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,PolII,H4K20me1;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:8:15:23:.
1	1249187	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=CPSF3L:NM_001256460:exon10:c.C795T:p.F265F,CPSF3L:NM_001256463:exon7:c.C579T:p.F193F,CPSF3L:NM_017871:exon9:c.C882T:p.F294F,CPSF3L:NM_001256456:exon11:c.C900T:p.F300F,CPSF3L:NM_001256462:exon7:c.C588T:p.F196F,,NONE(dist=NONE),NONE(dist=NONE),UNKNOWN,ENSG00000127054:ENST00000528879:exon8:c.C817T:p.R273C,;UCG=unknown;ENS=nonsynonymous_SNV;ENSGN=ENSG00000127054;MT=intergenic;MTGN=.;GN=CPSF3L;RSID=rs12142199;CD=.;HT=.;HC=.;HD=.;HP=.;AV=765;AT=3639;EV=6861;ET=1739;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.38;TAMR=0.50;TASN=0.02;TAFR=0.08;TEUR=0.80;SF=Catalytic_component_of_the_Integrator_complex,_a_complex_involved_in_the_small_nuclear_RNAs_(snRNA)_U1_and_U2_transcription_and_in_their_3'-box-dependent_processing._The_Integrator_complex_is_associated_with_the_C-terminal_domain_(CTD)_of_RNA_polymerase_II_largest_subunit_(POLR2A)_and_is_recruited_to_the_U1_and_U2_snRNAs_genes._Mediates_the_snRNAs_3'_cleavage.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,PolII,H4K20me1;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:69:74:143:.
1	1254136	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=CPSF3L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000127054;UCG=UTR3;ENS=intronic;ENSGN=ENSG00000127054;MT=intergenic;MTGN=.;GN=CPSF3L;RSID=rs4970432;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.75;TAMR=0.82;TASN=0.83;TAFR=0.32;TEUR=0.92;SF=Catalytic_component_of_the_Integrator_complex,_a_complex_involved_in_the_small_nuclear_RNAs_(snRNA)_U1_and_U2_transcription_and_in_their_3'-box-dependent_processing._The_Integrator_complex_is_associated_with_the_C-terminal_domain_(CTD)_of_RNA_polymerase_II_largest_subunit_(POLR2A)_and_is_recruited_to_the_U1_and_U2_snRNAs_genes._Mediates_the_snRNAs_3'_cleavage.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	0/1:18:15:33:.
1	1254255	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=CPSF3L,NONE(dist=NONE),NONE(dist=NONE),UNKNOWN,ENSG00000127054;UCG=unknown;ENS=intronic;ENSGN=ENSG00000127054;MT=intergenic;MTGN=.;GN=CPSF3L;RSID=rs62623580;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.07;TAMR=0.09;TASN=0.08;TAFR=0.14;TEUR=0.01;SF=Catalytic_component_of_the_Integrator_complex,_a_complex_involved_in_the_small_nuclear_RNAs_(snRNA)_U1_and_U2_transcription_and_in_their_3'-box-dependent_processing._The_Integrator_complex_is_associated_with_the_C-terminal_domain_(CTD)_of_RNA_polymerase_II_largest_subunit_(POLR2A)_and_is_recruited_to_the_U1_and_U2_snRNAs_genes._Mediates_the_snRNAs_3'_cleavage.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	0/1:81:90:171:.
1	1254436	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=CPSF3L,NONE(dist=NONE),NONE(dist=NONE),UNKNOWN,ENSG00000127054;UCG=unknown;ENS=intronic;ENSGN=ENSG00000127054;MT=intergenic;MTGN=.;GN=CPSF3L;RSID=rs1886773;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.88;TAMR=0.89;TASN=0.83;TAFR=0.81;TEUR=0.96;SF=Catalytic_component_of_the_Integrator_complex,_a_complex_involved_in_the_small_nuclear_RNAs_(snRNA)_U1_and_U2_transcription_and_in_their_3'-box-dependent_processing._The_Integrator_complex_is_associated_with_the_C-terminal_domain_(CTD)_of_RNA_polymerase_II_largest_subunit_(POLR2A)_and_is_recruited_to_the_U1_and_U2_snRNAs_genes._Mediates_the_snRNAs_3'_cleavage.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:26:39:65:.
1	1254443	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=CPSF3L,NONE(dist=NONE),NONE(dist=NONE),UNKNOWN,ENSG00000127054;UCG=unknown;ENS=intronic;ENSGN=ENSG00000127054;MT=intergenic;MTGN=.;GN=CPSF3L;RSID=rs1886772;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.75;TAMR=0.82;TASN=0.83;TAFR=0.32;TEUR=0.92;SF=Catalytic_component_of_the_Integrator_complex,_a_complex_involved_in_the_small_nuclear_RNAs_(snRNA)_U1_and_U2_transcription_and_in_their_3'-box-dependent_processing._The_Integrator_complex_is_associated_with_the_C-terminal_domain_(CTD)_of_RNA_polymerase_II_largest_subunit_(POLR2A)_and_is_recruited_to_the_U1_and_U2_snRNAs_genes._Mediates_the_snRNAs_3'_cleavage.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:28:40:68:.
1	1254841	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=CPSF3L:NM_001256460:exon5:c.G177C:p.G59G,CPSF3L:NM_017871:exon4:c.G264C:p.G88G,CPSF3L:NM_001256456:exon6:c.G282C:p.G94G,,NONE(dist=NONE),NONE(dist=NONE),UNKNOWN,ENSG00000127054:ENST00000527719:exon5:c.G282C:p.G94G,ENSG00000127054:ENST00000540437:exon6:c.G282C:p.G94G,ENSG00000127054:ENST00000530031:exon5:c.G405C:p.G135G,ENSG00000127054:ENST00000545578:exon5:c.G177C:p.G59G,ENSG00000127054:ENST00000450926:exon4:c.G264C:p.G88G,ENSG00000127054:ENST00000434694:exon4:c.G264C:p.G88G,ENSG00000127054:ENST00000435064:exon4:c.G264C:p.G88G,ENSG00000127054:ENST00000528879:exon4:c.G264C:p.G88G,ENSG00000127054:ENST00000498476:exon6:c.G444C:p.G148G,ENSG00000127054:ENST00000534345:exon4:c.G267C:p.G89G,;UCG=unknown;ENS=synonymous_SNV;ENSGN=ENSG00000127054;MT=intergenic;MTGN=.;GN=CPSF3L;RSID=rs10907179;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1754;AT=2652;EV=8017;ET=583;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.75;TAMR=0.82;TASN=0.83;TAFR=0.32;TEUR=0.92;SF=Catalytic_component_of_the_Integrator_complex,_a_complex_involved_in_the_small_nuclear_RNAs_(snRNA)_U1_and_U2_transcription_and_in_their_3'-box-dependent_processing._The_Integrator_complex_is_associated_with_the_C-terminal_domain_(CTD)_of_RNA_polymerase_II_largest_subunit_(POLR2A)_and_is_recruited_to_the_U1_and_U2_snRNAs_genes._Mediates_the_snRNAs_3'_cleavage.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:17:11:28:.
1	1257593	.	A	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=CPSF3L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000127054;UCG=intronic;ENS=intronic;ENSGN=ENSG00000127054;MT=intergenic;MTGN=.;GN=CPSF3L;RSID=rs1810745;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.88;TAMR=0.88;TASN=0.83;TAFR=0.83;TEUR=0.94;SF=Catalytic_component_of_the_Integrator_complex,_a_complex_involved_in_the_small_nuclear_RNAs_(snRNA)_U1_and_U2_transcription_and_in_their_3'-box-dependent_processing._The_Integrator_complex_is_associated_with_the_C-terminal_domain_(CTD)_of_RNA_polymerase_II_largest_subunit_(POLR2A)_and_is_recruited_to_the_U1_and_U2_snRNAs_genes._Mediates_the_snRNAs_3'_cleavage.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	1262966	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=GLTPD1:NM_001029885:exon3:c.C468T:p.R156R,,GLTPD1:uc001aeo.3:exon3:c.C468T:p.R156R,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000224051:ENST00000343938:exon3:c.C468T:p.R156R,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000224051;MT=intergenic;MTGN=.;GN=GLTPD1;RSID=rs307349;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2542;AT=1832;EV=7992;ET=590;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.78;TAMR=0.85;TASN=0.83;TAFR=0.47;TEUR=0.92;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H4K20me1,H3K36me3,H2BK5me1;ENC=Histone	GT:VR:RR:DP:GQ	0/1:23:25:48:.
1	1263144	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=GLTPD1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000224051;UCG=UTR3;ENS=UTR3;ENSGN=ENSG00000224051;MT=intergenic;MTGN=.;GN=GLTPD1;RSID=rs307350;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3546;AT=612;EV=7868;ET=540;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.84;TAMR=0.86;TASN=0.80;TAFR=0.77;TEUR=0.90;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H4K20me1,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:10:10:20:.
1	1268159	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=TAS1R3:NM_152228:exon3:c.C1248T:p.P416P,,NONE(dist=NONE),NONE(dist=NONE),TAS1R3:uc010nyk.2:exon3:c.C1248T:p.P416P,,ENSG00000169962:ENST00000339381:exon3:c.C1248T:p.P416P,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000169962;MT=intergenic;MTGN=.;GN=TAS1R3;RSID=rs3813210;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1174;AT=3222;EV=342;ET=8252;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.13;TAMR=0.14;TASN=0.08;TAFR=0.31;TEUR=0.04;SF=Putative_taste_receptor._TAS1R1/TAS1R3_responds_to_the_umami_taste_stimulus_(the_taste_of_monosodium_glutamate)._TAS1R2/TAS1R3_recognizes_diverse_natural_and_synthetic_sweeteners._TAS1R3_is_essential_for_the_recognition_and_response_to_the_disaccharide_trehalose_(By_similarity)._Sequence_differences_within_and_between_species_can_significantly_influence_the_selectivity_and_specificity_of_taste_responses.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=PolII,H3K27me3,H4K20me1,H3K36me3,H3K4me1,DNase1;ENC=Polymerase,Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:13:19:32:.
1	1268195	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=TAS1R3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000169962;UCG=intronic;ENS=intronic;ENSGN=ENSG00000169962;MT=intergenic;MTGN=.;GN=TAS1R3;RSID=rs3813211;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1200;AT=3188;EV=201;ET=8381;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.12;TAMR=0.12;TASN=0.08;TAFR=0.32;TEUR=0.02;SF=Putative_taste_receptor._TAS1R1/TAS1R3_responds_to_the_umami_taste_stimulus_(the_taste_of_monosodium_glutamate)._TAS1R2/TAS1R3_recognizes_diverse_natural_and_synthetic_sweeteners._TAS1R3_is_essential_for_the_recognition_and_response_to_the_disaccharide_trehalose_(By_similarity)._Sequence_differences_within_and_between_species_can_significantly_influence_the_selectivity_and_specificity_of_taste_responses.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=PolII,H3K27me3,H4K20me1,H3K36me3,H3K4me1,DNase1;ENC=Polymerase,Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:12:19:31:.
1	1268847	.	T	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=TAS1R3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000169962;UCG=intronic;ENS=intronic;ENSGN=ENSG00000169962;MT=intergenic;MTGN=.;GN=TAS1R3;RSID=rs307378;CD=.;HT=.;HC=.;HD=.;HP=.;AV=4360;AT=44;EV=8345;ET=251;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.96;TAMR=0.99;TASN=0.91;TAFR=0.99;TEUR=0.97;SF=Putative_taste_receptor._TAS1R1/TAS1R3_responds_to_the_umami_taste_stimulus_(the_taste_of_monosodium_glutamate)._TAS1R2/TAS1R3_recognizes_diverse_natural_and_synthetic_sweeteners._TAS1R3_is_essential_for_the_recognition_and_response_to_the_disaccharide_trehalose_(By_similarity)._Sequence_differences_within_and_between_species_can_significantly_influence_the_selectivity_and_specificity_of_taste_responses.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=PolII,H4K20me1,H3K36me3,DNase1;ENC=Polymerase,Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:15:0:15:.
1	1269004	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=TAS1R3:NM_152228:exon6:c.C1719T:p.L573L,,NONE(dist=NONE),NONE(dist=NONE),TAS1R3:uc010nyk.2:exon6:c.C1719T:p.L573L,,ENSG00000169962:ENST00000339381:exon6:c.C1719T:p.L573L,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000169962;MT=intergenic;MTGN=.;GN=TAS1R3;RSID=rs140035477;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3;AT=4391;EV=19;ET=8573;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.02;TAMR=0.08;TASN=0.01;TAFR=0.0020;TEUR=0.0040;SF=Putative_taste_receptor._TAS1R1/TAS1R3_responds_to_the_umami_taste_stimulus_(the_taste_of_monosodium_glutamate)._TAS1R2/TAS1R3_recognizes_diverse_natural_and_synthetic_sweeteners._TAS1R3_is_essential_for_the_recognition_and_response_to_the_disaccharide_trehalose_(By_similarity)._Sequence_differences_within_and_between_species_can_significantly_influence_the_selectivity_and_specificity_of_taste_responses.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=PolII,H4K20me1,H3K36me3,DNase1;ENC=Polymerase,Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:103:83:186:.
1	1269066	.	G	T	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=TAS1R3:NM_152228:exon6:c.G1781T:p.R594L,,TAS1R3:uc010nyk.2:exon6:c.G1781T:p.R594L,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000169962:ENST00000339381:exon6:c.G1781T:p.R594L,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000169962;MT=intergenic;MTGN=.;GN=TAS1R3;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Putative_taste_receptor._TAS1R1/TAS1R3_responds_to_the_umami_taste_stimulus_(the_taste_of_monosodium_glutamate)._TAS1R2/TAS1R3_recognizes_diverse_natural_and_synthetic_sweeteners._TAS1R3_is_essential_for_the_recognition_and_response_to_the_disaccharide_trehalose_(By_similarity)._Sequence_differences_within_and_between_species_can_significantly_influence_the_selectivity_and_specificity_of_taste_responses.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.059000;NC=0.010000;NE=0.058;NF=B;NG=0.193840;NH=N;NI=0.066808;NJ=N;NK=1.5;NL=low;NM=GPCR,_family_3,_C-terminal_(2),;ENN=PolII,H3K36me3;ENC=Polymerase,Histone	GT:VR:RR:DP:GQ	0/0:5:194:199:.
1	1269554	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=TAS1R3:NM_152228:exon6:c.T2269C:p.C757R,,NONE(dist=NONE),NONE(dist=NONE),TAS1R3:uc010nyk.2:exon6:c.T2269C:p.C757R,,ENSG00000169962:ENST00000339381:exon6:c.T2269C:p.C757R,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000169962;MT=intergenic;MTGN=.;GN=TAS1R3;RSID=rs307377;CD=.;HT=.;HC=.;HD=.;HP=.;AV=4332;AT=44;EV=8325;ET=249;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.96;TAMR=0.99;TASN=0.91;TAFR=0.99;TEUR=0.97;SF=Putative_taste_receptor._TAS1R1/TAS1R3_responds_to_the_umami_taste_stimulus_(the_taste_of_monosodium_glutamate)._TAS1R2/TAS1R3_recognizes_diverse_natural_and_synthetic_sweeteners._TAS1R3_is_essential_for_the_recognition_and_response_to_the_disaccharide_trehalose_(By_similarity)._Sequence_differences_within_and_between_species_can_significantly_influence_the_selectivity_and_specificity_of_taste_responses.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.627000;NC=0.330000;NE=0.0;NF=B;NG=0.047555;NH=N;NI=0.000126;NJ=N;NK=-1.79;NL=neutral;NM=GPCR,_family_3,_C-terminal_(2),;ENN=PolII,H3K36me3,H4K20me1,H2BK5me1;ENC=Polymerase,Histone	GT:VR:RR:DP:GQ	1/1:93:0:93:.
1	1270453	.	C	T	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=downstream;GI=DVL1,TAS1R3,NONE(dist=NONE),NONE(dist=NONE),ENSG00000169962;UCG=downstream;ENS=UTR3;ENSGN=ENSG00000169962;MT=intergenic;MTGN=.;GN=DVL1;RSID=rs11488701;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.09;TAMR=0.11;TASN=0.08;TAFR=0.18;TEUR=0.02;SF=Participates_in_Wnt_signaling_by_binding_to_the_cytoplasmic_C-terminus_of_frizzled_family_members_and_transducing_the_Wnt_signal_to_down-stream_effectors._Plays_a_role_both_in_canonical_and_non-canonical_Wnt_signaling._Plays_a_role_in_the_signal_transduction_pathways_mediated_by_multiple_Wnt_genes._Required_for_LEF1_activation_upon_WNT1_and_WNT3A_signaling._DVL1_and_PAK1_form_a_ternary_complex_with_MUSK_which_is_important_for_MUSK-dependent_regulation_of_AChR_clustering_during_the_formation_of_the_neuromuscular_junction_(NMJ).;SD=.;SM=Ubiquitinated,_undergoes_both_'Lys-48'-linked_ubiquitination,_leading_to_its_subsequent_degradation_by_the_ubiquitin-proteasome_pathway,_and_'Lys-63'-linked_ubiquitination._The_interaction_with_INVS_is_required_for_ubiquitination._Deubiquitinated_by_CYLD,_which_acts_on_'Lys-63'-linked_ubiquitin_chains_(By_similarity).;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=PolII,H3K36me3,Nrsf,DNase1,Sin3Ak20,ZBTB7A;ENC=Polymerase,Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:3:2:5:.
1	1271942	.	C	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=DVL1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000107404;UCG=intronic;ENS=intronic;ENSGN=ENSG00000107404;MT=intergenic;MTGN=.;GN=DVL1;RSID=rs111315662;CD=.;HT=.;HC=.;HD=.;HP=.;AV=552;AT=3164;EV=230;ET=7508;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.11;TAMR=0.12;TASN=0.08;TAFR=0.25;TEUR=0.04;SF=Participates_in_Wnt_signaling_by_binding_to_the_cytoplasmic_C-terminus_of_frizzled_family_members_and_transducing_the_Wnt_signal_to_down-stream_effectors._Plays_a_role_both_in_canonical_and_non-canonical_Wnt_signaling._Plays_a_role_in_the_signal_transduction_pathways_mediated_by_multiple_Wnt_genes._Required_for_LEF1_activation_upon_WNT1_and_WNT3A_signaling._DVL1_and_PAK1_form_a_ternary_complex_with_MUSK_which_is_important_for_MUSK-dependent_regulation_of_AChR_clustering_during_the_formation_of_the_neuromuscular_junction_(NMJ).;SD=.;SM=Ubiquitinated,_undergoes_both_'Lys-48'-linked_ubiquitination,_leading_to_its_subsequent_degradation_by_the_ubiquitin-proteasome_pathway,_and_'Lys-63'-linked_ubiquitination._The_interaction_with_INVS_is_required_for_ubiquitination._Deubiquitinated_by_CYLD,_which_acts_on_'Lys-63'-linked_ubiquitin_chains_(By_similarity).;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:4:1:5:.
1	1275065	.	G	A	2	low_snpqual;single_strand;low_VariantReads;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=DVL1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000107404;UCG=UTR5;ENS=intronic;ENSGN=ENSG00000107404;MT=intergenic;MTGN=.;GN=DVL1;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Participates_in_Wnt_signaling_by_binding_to_the_cytoplasmic_C-terminus_of_frizzled_family_members_and_transducing_the_Wnt_signal_to_down-stream_effectors._Plays_a_role_both_in_canonical_and_non-canonical_Wnt_signaling._Plays_a_role_in_the_signal_transduction_pathways_mediated_by_multiple_Wnt_genes._Required_for_LEF1_activation_upon_WNT1_and_WNT3A_signaling._DVL1_and_PAK1_form_a_ternary_complex_with_MUSK_which_is_important_for_MUSK-dependent_regulation_of_AChR_clustering_during_the_formation_of_the_neuromuscular_junction_(NMJ).;SD=.;SM=Ubiquitinated,_undergoes_both_'Lys-48'-linked_ubiquitination,_leading_to_its_subsequent_degradation_by_the_ubiquitin-proteasome_pathway,_and_'Lys-63'-linked_ubiquitination._The_interaction_with_INVS_is_required_for_ubiquitination._Deubiquitinated_by_CYLD,_which_acts_on_'Lys-63'-linked_ubiquitin_chains_(By_similarity).;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:2:148:150:.
1	1275291	.	G	A	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=DVL1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000107404;UCG=intronic;ENS=intronic;ENSGN=ENSG00000107404;MT=intergenic;MTGN=.;GN=DVL1;RSID=rs11582808;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.51;TAMR=0.50;TASN=0.49;TAFR=0.54;TEUR=0.51;SF=Participates_in_Wnt_signaling_by_binding_to_the_cytoplasmic_C-terminus_of_frizzled_family_members_and_transducing_the_Wnt_signal_to_down-stream_effectors._Plays_a_role_both_in_canonical_and_non-canonical_Wnt_signaling._Plays_a_role_in_the_signal_transduction_pathways_mediated_by_multiple_Wnt_genes._Required_for_LEF1_activation_upon_WNT1_and_WNT3A_signaling._DVL1_and_PAK1_form_a_ternary_complex_with_MUSK_which_is_important_for_MUSK-dependent_regulation_of_AChR_clustering_during_the_formation_of_the_neuromuscular_junction_(NMJ).;SD=.;SM=Ubiquitinated,_undergoes_both_'Lys-48'-linked_ubiquitination,_leading_to_its_subsequent_degradation_by_the_ubiquitin-proteasome_pathway,_and_'Lys-63'-linked_ubiquitination._The_interaction_with_INVS_is_required_for_ubiquitination._Deubiquitinated_by_CYLD,_which_acts_on_'Lys-63'-linked_ubiquitin_chains_(By_similarity).;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	1275716	.	T	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=DVL1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000107404;UCG=intronic;ENS=intronic;ENSGN=ENSG00000107404;MT=intergenic;MTGN=.;GN=DVL1;RSID=rs112871502;CD=.;HT=.;HC=.;HD=.;HP=.;AV=547;AT=3855;EV=200;ET=8392;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.09;TAMR=0.11;TASN=0.08;TAFR=0.18;TEUR=0.02;SF=Participates_in_Wnt_signaling_by_binding_to_the_cytoplasmic_C-terminus_of_frizzled_family_members_and_transducing_the_Wnt_signal_to_down-stream_effectors._Plays_a_role_both_in_canonical_and_non-canonical_Wnt_signaling._Plays_a_role_in_the_signal_transduction_pathways_mediated_by_multiple_Wnt_genes._Required_for_LEF1_activation_upon_WNT1_and_WNT3A_signaling._DVL1_and_PAK1_form_a_ternary_complex_with_MUSK_which_is_important_for_MUSK-dependent_regulation_of_AChR_clustering_during_the_formation_of_the_neuromuscular_junction_(NMJ).;SD=.;SM=Ubiquitinated,_undergoes_both_'Lys-48'-linked_ubiquitination,_leading_to_its_subsequent_degradation_by_the_ubiquitin-proteasome_pathway,_and_'Lys-63'-linked_ubiquitination._The_interaction_with_INVS_is_required_for_ubiquitination._Deubiquitinated_by_CYLD,_which_acts_on_'Lys-63'-linked_ubiquitin_chains_(By_similarity).;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:26:30:56:.
1	1275956	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=DVL1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000107404;UCG=intronic;ENS=intronic;ENSGN=ENSG00000107404;MT=intergenic;MTGN=.;GN=DVL1;RSID=rs111883533;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.12;TAMR=0.12;TASN=0.08;TAFR=0.29;TEUR=0.04;SF=Participates_in_Wnt_signaling_by_binding_to_the_cytoplasmic_C-terminus_of_frizzled_family_members_and_transducing_the_Wnt_signal_to_down-stream_effectors._Plays_a_role_both_in_canonical_and_non-canonical_Wnt_signaling._Plays_a_role_in_the_signal_transduction_pathways_mediated_by_multiple_Wnt_genes._Required_for_LEF1_activation_upon_WNT1_and_WNT3A_signaling._DVL1_and_PAK1_form_a_ternary_complex_with_MUSK_which_is_important_for_MUSK-dependent_regulation_of_AChR_clustering_during_the_formation_of_the_neuromuscular_junction_(NMJ).;SD=.;SM=Ubiquitinated,_undergoes_both_'Lys-48'-linked_ubiquitination,_leading_to_its_subsequent_degradation_by_the_ubiquitin-proteasome_pathway,_and_'Lys-63'-linked_ubiquitination._The_interaction_with_INVS_is_required_for_ubiquitination._Deubiquitinated_by_CYLD,_which_acts_on_'Lys-63'-linked_ubiquitin_chains_(By_similarity).;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1;ENC=Histone	GT:VR:RR:DP:GQ	0/1:9:13:22:.
1	1277533	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=DVL1:NM_004421:exon4:c.A366G:p.P122P,,NONE(dist=NONE),NONE(dist=NONE),DVL1:uc001aer.4:exon4:c.A366G:p.P122P,,ENSG00000107404:ENST00000378891:exon4:c.A366G:p.P122P,ENSG00000107404:ENST00000378888:exon4:c.A366G:p.P122P,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000107404;MT=intergenic;MTGN=.;GN=DVL1;RSID=rs307362;CD=.;HT=.;HC=.;HD=.;HP=.;AV=4367;AT=1;EV=8547;ET=11;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.99;TAMR=0.99;TASN=0.99;TAFR=0.99;TEUR=0.99;SF=Participates_in_Wnt_signaling_by_binding_to_the_cytoplasmic_C-terminus_of_frizzled_family_members_and_transducing_the_Wnt_signal_to_down-stream_effectors._Plays_a_role_both_in_canonical_and_non-canonical_Wnt_signaling._Plays_a_role_in_the_signal_transduction_pathways_mediated_by_multiple_Wnt_genes._Required_for_LEF1_activation_upon_WNT1_and_WNT3A_signaling._DVL1_and_PAK1_form_a_ternary_complex_with_MUSK_which_is_important_for_MUSK-dependent_regulation_of_AChR_clustering_during_the_formation_of_the_neuromuscular_junction_(NMJ).;SD=.;SM=Ubiquitinated,_undergoes_both_'Lys-48'-linked_ubiquitination,_leading_to_its_subsequent_degradation_by_the_ubiquitin-proteasome_pathway,_and_'Lys-63'-linked_ubiquitination._The_interaction_with_INVS_is_required_for_ubiquitination._Deubiquitinated_by_CYLD,_which_acts_on_'Lys-63'-linked_ubiquitin_chains_(By_similarity).;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	1/1:35:0:35:.
1	1277649	.	G	T	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=DVL1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000107404;UCG=intronic;ENS=intronic;ENSGN=ENSG00000107404;MT=intergenic;MTGN=.;GN=DVL1;RSID=rs146525333;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.08;TAMR=0.11;TASN=0.07;TAFR=0.18;TEUR=0.02;SF=Participates_in_Wnt_signaling_by_binding_to_the_cytoplasmic_C-terminus_of_frizzled_family_members_and_transducing_the_Wnt_signal_to_down-stream_effectors._Plays_a_role_both_in_canonical_and_non-canonical_Wnt_signaling._Plays_a_role_in_the_signal_transduction_pathways_mediated_by_multiple_Wnt_genes._Required_for_LEF1_activation_upon_WNT1_and_WNT3A_signaling._DVL1_and_PAK1_form_a_ternary_complex_with_MUSK_which_is_important_for_MUSK-dependent_regulation_of_AChR_clustering_during_the_formation_of_the_neuromuscular_junction_(NMJ).;SD=.;SM=Ubiquitinated,_undergoes_both_'Lys-48'-linked_ubiquitination,_leading_to_its_subsequent_degradation_by_the_ubiquitin-proteasome_pathway,_and_'Lys-63'-linked_ubiquitination._The_interaction_with_INVS_is_required_for_ubiquitination._Deubiquitinated_by_CYLD,_which_acts_on_'Lys-63'-linked_ubiquitin_chains_(By_similarity).;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,PolII,DNase1;ENC=Histone,Polymerase,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:4:2:6:.
1	1277735	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=DVL1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000107404;UCG=intronic;ENS=intronic;ENSGN=ENSG00000107404;MT=intergenic;MTGN=.;GN=DVL1;RSID=rs140992194;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3;AT=4279;EV=12;ET=8426;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.02;TAMR=0.08;TASN=0.01;TAFR=0.0020;TEUR=0.0026;SF=Participates_in_Wnt_signaling_by_binding_to_the_cytoplasmic_C-terminus_of_frizzled_family_members_and_transducing_the_Wnt_signal_to_down-stream_effectors._Plays_a_role_both_in_canonical_and_non-canonical_Wnt_signaling._Plays_a_role_in_the_signal_transduction_pathways_mediated_by_multiple_Wnt_genes._Required_for_LEF1_activation_upon_WNT1_and_WNT3A_signaling._DVL1_and_PAK1_form_a_ternary_complex_with_MUSK_which_is_important_for_MUSK-dependent_regulation_of_AChR_clustering_during_the_formation_of_the_neuromuscular_junction_(NMJ).;SD=.;SM=Ubiquitinated,_undergoes_both_'Lys-48'-linked_ubiquitination,_leading_to_its_subsequent_degradation_by_the_ubiquitin-proteasome_pathway,_and_'Lys-63'-linked_ubiquitination._The_interaction_with_INVS_is_required_for_ubiquitination._Deubiquitinated_by_CYLD,_which_acts_on_'Lys-63'-linked_ubiquitin_chains_(By_similarity).;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,PolII,DNase1;ENC=Histone,Polymerase,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:10:7:17:.
1	1278237	.	T	C	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=DVL1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000107404;UCG=intronic;ENS=intronic;ENSGN=ENSG00000107404;MT=intergenic;MTGN=.;GN=DVL1;RSID=rs307361;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.96;TAMR=0.99;TASN=0.91;TAFR=0.99;TEUR=0.97;SF=Participates_in_Wnt_signaling_by_binding_to_the_cytoplasmic_C-terminus_of_frizzled_family_members_and_transducing_the_Wnt_signal_to_down-stream_effectors._Plays_a_role_both_in_canonical_and_non-canonical_Wnt_signaling._Plays_a_role_in_the_signal_transduction_pathways_mediated_by_multiple_Wnt_genes._Required_for_LEF1_activation_upon_WNT1_and_WNT3A_signaling._DVL1_and_PAK1_form_a_ternary_complex_with_MUSK_which_is_important_for_MUSK-dependent_regulation_of_AChR_clustering_during_the_formation_of_the_neuromuscular_junction_(NMJ).;SD=.;SM=Ubiquitinated,_undergoes_both_'Lys-48'-linked_ubiquitination,_leading_to_its_subsequent_degradation_by_the_ubiquitin-proteasome_pathway,_and_'Lys-63'-linked_ubiquitination._The_interaction_with_INVS_is_required_for_ubiquitination._Deubiquitinated_by_CYLD,_which_acts_on_'Lys-63'-linked_ubiquitin_chains_(By_similarity).;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:22:0:22:.
1	1288583	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=MXRA8,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162576;UCG=UTR3;ENS=UTR3;ENSGN=ENSG00000162576;MT=intergenic;MTGN=.;GN=MXRA8;RSID=rs3845295;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.87;TAMR=0.95;TASN=0.84;TAFR=0.73;TEUR=0.93;SF=May_play_a_role_in_the_maturation_and_maintenance_of_blood-brain_barrier_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,PolII,H3K27me3;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	1/1:36:0:36:.
1	1288823	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=MXRA8,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162576;UCG=UTR3;ENS=UTR3;ENSGN=ENSG00000162576;MT=intergenic;MTGN=.;GN=MXRA8;RSID=rs2296471;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.79;TAMR=0.85;TASN=0.83;TAFR=0.48;TEUR=0.92;SF=May_play_a_role_in_the_maturation_and_maintenance_of_blood-brain_barrier_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,PolII,H3K27me3,DNase1;ENC=Histone,Polymerase,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:18:12:30:.
1	1289911	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=MXRA8,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162576;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162576;MT=intergenic;MTGN=.;GN=MXRA8;RSID=rs4970365;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3452;AT=924;EV=8023;ET=537;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.84;TAMR=0.87;TASN=0.83;TAFR=0.71;TEUR=0.93;SF=May_play_a_role_in_the_maturation_and_maintenance_of_blood-brain_barrier_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3,DNase1,H3K4me2,H3K4me3,PolII;ENC=Histone,Open_Chromatin,Polymerase	GT:VR:RR:DP:GQ	0/1:24:25:49:.
1	1293764	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=MXRA8,NONE(dist=NONE),NONE(dist=NONE),ENSG00000162576;UCG=intronic;ENS=intronic;ENSGN=ENSG00000162576;MT=intergenic;MTGN=.;GN=MXRA8;RSID=rs34841888;CD=.;HT=.;HC=.;HD=.;HP=.;AV=253;AT=1131;EV=2592;ET=590;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.39;TAMR=0.52;TASN=0.02;TAFR=0.09;TEUR=0.82;SF=May_play_a_role_in_the_maturation_and_maintenance_of_blood-brain_barrier_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K27me3,H3K4me3,H3K27ac,H3K4me2,H3K18ac,DNase1,H4K91ac,H3K4ac,H4K5ac,PolII;ENC=Histone,Open_Chromatin,Polymerase	GT:VR:RR:DP:GQ	0/1:19:25:44:.
1	1310074	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AURKAIP1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000175756;UCG=intronic;ENS=intronic;ENSGN=ENSG00000175756;MT=intergenic;MTGN=.;GN=AURKAIP1;RSID=rs2765035;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2871;AT=1413;EV=8026;ET=370;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.84;TAMR=0.92;TASN=0.90;TAFR=0.59;TEUR=0.94;SF=May_act_as_a_negative_regulator_of_Aurora-A_kinase,_by_down-regulation_through_proteasome-dependent_degradation.;SD=.;SM=.;SX=Ubiquitously_expressed_and_especially_highly_expressed_in_heart,_skeletal_muscle_and_testis.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H3K27me3,H3K4me3,H3K4me2,H3K79me2,H3K9ac,H3K27ac,PolII,DNase1,EBF,Gabp;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:123:1:124:.
1	1323078	.	A	G	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=CCNL2,NONE(dist=NONE),NONE(dist=NONE),ENSG00000221978;UCG=intronic;ENS=intronic;ENSGN=ENSG00000221978;MT=intergenic;MTGN=.;GN=CCNL2;RSID=rs12729599;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.39;TAMR=0.52;TASN=0.02;TAFR=0.08;TEUR=0.81;SF=Transcriptional_regulator_which_participates_in_regulating_the_pre-mRNA_splicing_process._Also_modulates_the_expression_of_critical_apoptotic_factor,_leading_to_cell_apoptosis.;SD=.;SM=.;SX=Ubiquitously_expressed,_with_a_higher_expression_level_observed_in_ovary,_heart,_liver_and_pancreas.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:4:9:13:.
1	1328971	.	C	T	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=CCNL2,NONE(dist=NONE),NONE(dist=NONE),ENSG00000221978;UCG=intronic;ENS=intronic;ENSGN=ENSG00000221978;MT=intergenic;MTGN=.;GN=CCNL2;RSID=rs11485864;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.07;TAMR=0.10;TASN=0.02;TAFR=0.19;TEUR=0.03;SF=Transcriptional_regulator_which_participates_in_regulating_the_pre-mRNA_splicing_process._Also_modulates_the_expression_of_critical_apoptotic_factor,_leading_to_cell_apoptosis.;SD=.;SM=.;SX=Ubiquitously_expressed,_with_a_higher_expression_level_observed_in_ovary,_heart,_liver_and_pancreas.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,PolII,H2BK5me1;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:3:4:7:.
1	1330608	.	C	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=CCNL2,NONE(dist=NONE),NONE(dist=NONE),ENSG00000221978;UCG=intronic;ENS=intronic;ENSGN=ENSG00000221978;MT=intergenic;MTGN=.;GN=CCNL2;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Transcriptional_regulator_which_participates_in_regulating_the_pre-mRNA_splicing_process._Also_modulates_the_expression_of_critical_apoptotic_factor,_leading_to_cell_apoptosis.;SD=.;SM=.;SX=Ubiquitously_expressed,_with_a_higher_expression_level_observed_in_ovary,_heart,_liver_and_pancreas.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:4:1:5:.
1	1333436	.	C	A	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=CCNL2,NONE(dist=NONE),NONE(dist=NONE),ENSG00000221978;UCG=intronic;ENS=intronic;ENSGN=ENSG00000221978;MT=intergenic;MTGN=.;GN=CCNL2;RSID=rs1240743;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.82;TAMR=0.77;TASN=1.00;TAFR=0.98;TEUR=0.60;SF=Transcriptional_regulator_which_participates_in_regulating_the_pre-mRNA_splicing_process._Also_modulates_the_expression_of_critical_apoptotic_factor,_leading_to_cell_apoptosis.;SD=.;SM=.;SX=Ubiquitously_expressed,_with_a_higher_expression_level_observed_in_ovary,_heart,_liver_and_pancreas.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K79me2,H3K4me3,H3K4me2,H3K27me3,H4K91ac,H3K9ac,H3K27ac,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:4:2:6:.
1	1354515	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=ANKRD65:NM_001145210:exon4:c.G1165C:p.E389Q,,NONE(dist=NONE),NONE(dist=NONE),ANKRD65:uc010nyo.2:exon4:c.G1165C:p.E389Q,,ENSG00000235098:ENST00000537107:exon4:c.G1165C:p.E389Q,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000235098;MT=intergenic;MTGN=.;GN=ANKRD65;RSID=rs904589;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.28;TAMR=0.22;TASN=0.12;TAFR=0.82;TEUR=0.09;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.272000;NC=0.670000;NE=0.0;NF=B;NG=.;NH=.;NI=.;NJ=.;NK=0.695;NL=neutral;NM=.;ENN=H3K27ac,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:76:77:153:.
1	1354594	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=ANKRD65:NM_001145210:exon4:c.T1086C:p.T362T,,NONE(dist=NONE),NONE(dist=NONE),ANKRD65:uc010nyo.2:exon4:c.T1086C:p.T362T,,ENSG00000235098:ENST00000537107:exon4:c.T1086C:p.T362T,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000235098;MT=intergenic;MTGN=.;GN=ANKRD65;RSID=rs3766165;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.22;TAMR=0.20;TASN=0.12;TAFR=0.55;TEUR=0.09;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27ac,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:33:39:72:.
1	1361641	.	C	T	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=TMEM88B:NM_001146685:exon1:c.C134T:p.P45L,,TMEM88B:uc010nyp.2:exon1:c.C134T:p.P45L,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000205116:ENST00000378821:exon1:c.C134T:p.P45L,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000205116;MT=intergenic;MTGN=.;GN=TMEM88B;RSID=rs12030806;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.60;TAMR=0.46;TASN=0.99;TAFR=0.83;TEUR=0.21;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,H3K4me3,PolII,H3K4me2,TAF1,H3K9ac;ENC=Histone,Open_Chromatin,Polymerase,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:5:1:6:.
1	1361818	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=TMEM88B,NONE(dist=NONE),NONE(dist=NONE),ENSG00000205116;UCG=intronic;ENS=intronic;ENSGN=ENSG00000205116;MT=intergenic;MTGN=.;GN=TMEM88B;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,H3K4me3,H3K4me2,H3K9ac;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:12:4:16:.
1	1386016	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR5;GI=ATAD3C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000215915;UCG=UTR5;ENS=UTR5;ENSGN=ENSG00000215915;MT=intergenic;MTGN=.;GN=ATAD3C;RSID=rs34301361;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.25;TAMR=0.29;TASN=0.38;TAFR=0.22;TEUR=0.15;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:80:87:167:.
1	1387348	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ATAD3C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000215915;UCG=intronic;ENS=intronic;ENSGN=ENSG00000215915;MT=intergenic;MTGN=.;GN=ATAD3C;RSID=rs1781143;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.37;TAMR=0.37;TASN=0.50;TAFR=0.52;TEUR=0.18;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:102:118:220:.
1	1387416	.	T	C	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ATAD3C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000215915;UCG=intronic;ENS=intronic;ENSGN=ENSG00000215915;MT=intergenic;MTGN=.;GN=ATAD3C;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:4:443:447:.
1	1387667	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ATAD3C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000215915;UCG=intronic;ENS=intronic;ENSGN=ENSG00000215915;MT=intergenic;MTGN=.;GN=ATAD3C;RSID=rs1781144;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=1.00;TAMR=1.00;TASN=1.00;TAFR=1.00;TEUR=1.00;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:55:0:55:.
1	1387726	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ATAD3C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000215915;UCG=intronic;ENS=intronic;ENSGN=ENSG00000215915;MT=intergenic;MTGN=.;GN=ATAD3C;RSID=rs9793066;CD=.;HT=.;HC=.;HD=.;HP=.;AV=242;AT=1142;EV=521;ET=2661;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.27;TAMR=0.35;TASN=0.39;TAFR=0.25;TEUR=0.16;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:83:90:173:.
1	1387854	.	G	A	2	low_snpqual;single_strand;low_VariantReads;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ATAD3C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000215915;UCG=intronic;ENS=intronic;ENSGN=ENSG00000215915;MT=intergenic;MTGN=.;GN=ATAD3C;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:2:164:166:.
1	1387891	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ATAD3C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000215915;UCG=intronic;ENS=intronic;ENSGN=ENSG00000215915;MT=intergenic;MTGN=.;GN=ATAD3C;RSID=rs1624483;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.60;TAMR=0.49;TASN=0.99;TAFR=0.86;TEUR=0.19;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:37:47:84:.
1	1387920	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ATAD3C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000215915;UCG=intronic;ENS=intronic;ENSGN=ENSG00000215915;MT=intergenic;MTGN=.;GN=ATAD3C;RSID=rs1625156;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.36;TAMR=0.38;TASN=0.49;TAFR=0.46;TEUR=0.19;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:22:30:52:.
1	1389695	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ATAD3C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000215915;UCG=intronic;ENS=intronic;ENSGN=ENSG00000215915;MT=intergenic;MTGN=.;GN=ATAD3C;RSID=rs35096659;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:40:41:81:.
